In the pursuit of personalized medicine, there is a growing demand for computational models with parameters that are easily obtainable to accelerate the development of potential solutions. Blood tests, owing to their affordability, accessibility, and routine use in healthcare, offer valuable biomarkers for assessing hemostatic balance in thrombotic and bleeding disorders. Incorporating these biomarkers into computational models of blood coagulation is crucial for creating patient-specific models, which allow for the analysis of the influence of these biomarkers on clot formation. This systematic review aims to examine how clinically relevant biomarkers are integrated into computational models of blood clot formation, thereby advancing discussions on integration methodologies, identifying current gaps, and recommending future research directions. A systematic review was conducted following the PRISMA protocol, focusing on ten clinically significant biomarkers associated with hemostatic disorders: D-dimer, fibrinogen, Von Willebrand factor, factor Ⅷ, P-selectin, prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin Ⅲ, protein C, and protein S. By utilizing this set of biomarkers, this review underscores their integration into computational models and emphasizes their integration in the context of venous thromboembolism and hemophilia. Eligibility criteria included mathematical models of thrombin generation, blood clotting, or fibrin formation under flow, incorporating at least one of these biomarkers. A total of 53 articles were included in this review. Results indicate that commonly used biomarkers such as D-dimer, PT, and APTT are rarely and superficially integrated into computational blood coagulation models. Additionally, the kinetic parameters governing the dynamics of blood clot formation demonstrated significant variability across studies, with discrepancies of up to 1, 000-fold. This review highlights a critical gap in the availability of computational models based on phenomenological or first-principles approaches that effectively incorporate affordable and routinely used clinical test results for predicting blood coagulation. This hinders the development of practical tools for clinical application, as current mathematical models often fail to consider precise, patient-specific values. This limitation is especially pronounced in patients with conditions such as hemophilia, protein C and S deficiencies, or antithrombin deficiency. Addressing these challenges by developing patient-specific models that account for kinetic variability is crucial for advancing personalized medicine in the field of hemostasis.
Citation: Mohamad Al Bannoud, Tiago Dias Martins, Silmara Aparecida de Lima Montalvão, Joyce Maria Annichino-Bizzacchi, Rubens Maciel Filho, Maria Regina Wolf Maciel. Integrating biomarkers for hemostatic disorders into computational models of blood clot formation: A systematic review[J]. Mathematical Biosciences and Engineering, 2024, 21(12): 7707-7739. doi: 10.3934/mbe.2024339
[1] | Luís J. del Valle, Lourdes Franco, Ramaz Katsarava, Jordi Puiggalí . Electrospun biodegradable polymers loaded with bactericide agents. AIMS Molecular Science, 2016, 3(1): 52-87. doi: 10.3934/molsci.2016.1.52 |
[2] | Mohamed Amine Ben Mlouka, Thomas Cousseau, Patrick Di Martino . Application of fluorescently labelled lectins for the study of polysaccharides in biofilms with a focus on biofouling of nanofiltration membranes. AIMS Molecular Science, 2016, 3(3): 338-356. doi: 10.3934/molsci.2016.3.338 |
[3] | Fohona S. Coulibaly, Bi-Botti C. Youan . Current status of lectin-based cancer diagnosis and therapy. AIMS Molecular Science, 2017, 4(1): 1-27. doi: 10.3934/molsci.2017.1.1 |
[4] | Benoît H. Lessard, Timothy P. Bender . Controlled and selective placement of boron subphthalocyanines on either chain end of polymers synthesized by nitroxide mediated polymerization. AIMS Molecular Science, 2015, 2(4): 411-426. doi: 10.3934/molsci.2015.4.411 |
[5] | Richard C. Petersen . Triclosan antimicrobial polymers. AIMS Molecular Science, 2016, 3(1): 88-103. doi: 10.3934/molsci.2016.1.88 |
[6] | Morgane Albanese, Justine Boyenval, Paola Marchese, Simone Sullalti, Annamaria Celli . The aliphatic counterpart of PET, PPT and PBT aromatic polyesters: effect of the molecular structure on thermo-mechanical properties. AIMS Molecular Science, 2016, 3(1): 32-51. doi: 10.3934/molsci.2016.1.32 |
[7] | Harkirat S. Sethi, Jessica L. Osier, Geordan L. Burks, Jennifer F. Lamar, Hana McFeeters, Robert L. McFeeters . Expedited isolation of natural product peptidyl-tRNA hydrolase inhibitors from a Pth1 affinity column. AIMS Molecular Science, 2017, 4(2): 175-184. doi: 10.3934/molsci.2017.2.175 |
[8] | Francisco dos Santos Farias, Vicente Paulo da Costa Neto, Cleriston Correia da Silva Souza, Daniela Vieira Chaves, Aurenivia Bonifácio . Differential metabolic rearrangements improve biomass and enhance the tolerance of two dwarf cashew (Anacardium occidentale L.) genotypes to salt stress. AIMS Molecular Science, 2024, 11(2): 206-220. doi: 10.3934/molsci.2024012 |
[9] | Yoshie Uchida, Masaki Honda, Rungaroon Waditee-Sirisattha, Hakuto Kageyama . Functional evaluation of saclipins A and B derived from the edible cyanobacterium Aphanothece sacrum: New bioactivities for anti-wrinkle and anti-hypertension. AIMS Molecular Science, 2025, 12(2): 113-121. doi: 10.3934/molsci.2025007 |
[10] | Viviana Imbua Levi Enoka, Gideon Mutie Kikuvi, Perpetual Wangui Ndung'u . Effect of garlic and onion extract chitosan nanoparticles on selected intestinal bacterial flora in indigenous rainbow rooster chicken in Kenya. AIMS Molecular Science, 2021, 8(2): 98-116. doi: 10.3934/molsci.2021008 |
In the pursuit of personalized medicine, there is a growing demand for computational models with parameters that are easily obtainable to accelerate the development of potential solutions. Blood tests, owing to their affordability, accessibility, and routine use in healthcare, offer valuable biomarkers for assessing hemostatic balance in thrombotic and bleeding disorders. Incorporating these biomarkers into computational models of blood coagulation is crucial for creating patient-specific models, which allow for the analysis of the influence of these biomarkers on clot formation. This systematic review aims to examine how clinically relevant biomarkers are integrated into computational models of blood clot formation, thereby advancing discussions on integration methodologies, identifying current gaps, and recommending future research directions. A systematic review was conducted following the PRISMA protocol, focusing on ten clinically significant biomarkers associated with hemostatic disorders: D-dimer, fibrinogen, Von Willebrand factor, factor Ⅷ, P-selectin, prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin Ⅲ, protein C, and protein S. By utilizing this set of biomarkers, this review underscores their integration into computational models and emphasizes their integration in the context of venous thromboembolism and hemophilia. Eligibility criteria included mathematical models of thrombin generation, blood clotting, or fibrin formation under flow, incorporating at least one of these biomarkers. A total of 53 articles were included in this review. Results indicate that commonly used biomarkers such as D-dimer, PT, and APTT are rarely and superficially integrated into computational blood coagulation models. Additionally, the kinetic parameters governing the dynamics of blood clot formation demonstrated significant variability across studies, with discrepancies of up to 1, 000-fold. This review highlights a critical gap in the availability of computational models based on phenomenological or first-principles approaches that effectively incorporate affordable and routinely used clinical test results for predicting blood coagulation. This hinders the development of practical tools for clinical application, as current mathematical models often fail to consider precise, patient-specific values. This limitation is especially pronounced in patients with conditions such as hemophilia, protein C and S deficiencies, or antithrombin deficiency. Addressing these challenges by developing patient-specific models that account for kinetic variability is crucial for advancing personalized medicine in the field of hemostasis.
Natural polymers are materials of natural origin with properties of biocompatibility, low cost, availability and lack of toxicity. These polymers, such as gums and mucilages, are increasingly preferred over synthetic materials due to their intrinsic properties; in addition to be considered alternative sources of raw materials for industrial applications.
As definition, gums are polysaccharides composed by multiple sugar units linked together to create large molecules with heterogeneous composition. Upon hydrolysis, they yield simple sugar units such as arabinose, galactose, glucose, mannose, xylose or uronic acids. The polysaccharide gums represent one of the most abundant industrial biomaterials and have been reported by several studies due to their sustainability, biodegradability and biosafety. Gums are abundant in nature and commonly found in many higher plants; in addition, they are frequently produced as a protection mechanism following plant injury [1].
Besides gums, the constituents of polysaccharides also include mucilages. Although their natural polymeric source, gums and mucilages have certain differences: gums readily dissolve in water, while mucilages form viscous masses; gums are considered pathological products, whereas mucilages are physiological products. In addition, their similarities are related to their broad range of physicochemical properties, which are widely used for applications including cosmetics, paper, pharmacy, textile, adhesive, inks, lithography, paint, explosive, and smoking products [2,3]. In order to avoid misinterpretations, it is important to distinguish the above-mentioned terms.
Mucilage is a polysaccharide mixture commonly found in various organs of many higher plant species. Due to its high variability in terms of chemical constituents, mucilage probably assumes a multitude of physiological functions in plants [4]. Mucilages found in rhizomes, roots and seed endosperms may act primarily as energy reserves [5], whereas foliar mucilages appear not to serve as storage carbohydrates. Generally, it has been assumed that foliar mucilages are merely secondary plant metabolites, but there was also reported that they may play a role in wound responses, frost tolerance, water transport, plant host-pathogen interactions, the ionic balance of plant cells, and as carbohydrate reserves. There is growing evidence that, due to the high concentration of hydroxyl groups in the polysaccharides, extracellular mucilages in particular have a high water-binding capacity and may play an important role in the drought resistance of certain plant species [2].
Natural gum is a term used to describe a group of naturally occurring polysaccharides. They have widespread industrial applications due to their ability either to form the gel, make the viscous solution or stabilize the emulsion systems [6]. Water-soluble gums are described as hydrocolloids; they are used for various applications, including dietary fibers [7], texture modifiers, stabilizers and/or emulsifiers [8,9], gelling agents [10], thickeners [11], coating agents [12,13] and packaging films [14]. Many natural gums form three dimensional interconnected molecular networks known as“gels”. The strength of the gel depends on its structure and concentration, as well as on factors such as temperature, pH, and ionic strength. The linear polysaccharides occupy greater volume than branched polymers of comparable molecular weight. Thus, at the same concentration, comparable linear polysaccharides exhibit greater viscosity. Therefore, it is difficult for the heterogeneous gum molecules to move freely without becoming entangled with each other (and any other large molecules also present). In addition, natural gums are often recognized by their swelling properties, which occurs due to the entrapment of large amounts of water between their chains and branches [1].
Cellulose, chitin, agar and starch are the most common polysaccharides used in industry. Regarding their broad range of applications, the preference for use of natural polymers is presumed over comparable synthetic materials due to their non-toxicity, low cost and availability. For instance, most of the natural gums are safe enough for oral consumption in the form of food additives or drug carriers [1]. In addition, synthesizing natural polymers as nanomaterials enhances the industrial applicability due to its larger surface, besides the intrinsic properties above mentioned. The present work considers the most recent literature dealing with natural polymers, including natural gums and mucilages, and their potential biotechnological applications. Moreover, we summarized information about their chemical structure, physicochemical and functional properties.
Gums and mucilages are sourced from the endosperm of plant seeds, plant exudates, tree or shrub exudates, seaweed extracts, fungi, bacteria, and animal sources, where they perform a number of structural and metabolic functions; it is important to highlight that plant sources provide the largest amounts of gums. Natural gums are categorized based on their origins, behaviour and chemical structures. Gums submitted to a hydrolysis process, because of their polysaccharide nature, produce an indefinite number of monosaccharides. Depending on the type of the products obtained by hydrolysis, gums can be further classified into pentosans and hexosans. Chemically, they are pathological products consisting of calcium, potassium and magnesium salts of complex substances known as polyuronides, whose sugar units can be separated by hydrolysis using dilute mineral acids, followed by separation of liberated monosaccharides using different chromatographic techniques [3]. Different sources of gums and mucilages are listed in Table 1.
Source | Name | Type | Reference |
Tree gum exudates | Arabic gum | Arabinogalactan | [21] |
Prosopis alba gum | Arabinogalactan | [22] | |
Acacia tortuosa gum | Arabinogalactan | [23] | |
Almond gum | Arabinogalactan | [24] | |
Albizia stipulata gum | Arabinogalactan | [25] | |
Acacia senegal gum | Arabinogalactan | [26] | |
Cashew gum | Galactan with glucose,arabinose,rhamnose,mannose and glucuronic acid units | [27] | |
Extracts | Pectin | Galacturonic acid with rhamnose,arabinose,galactose,xylose,and glucose units | [28] |
Seeds | Cassia spectabilis gum | Galactomannan | [29] |
Guar gum | Galactomannan | [30] | |
Cassia nodosa gum | Galactomannan | [31] | |
Cassia grandis gum | Galactomannan | [32] | |
Fenugreek | Galactomannan | [33] | |
Locust bean gum | Galactomannan | [34] | |
Starch | Glucan | [35] | |
Hymenaea courbaril gum | Xyloglucan | [36] | |
Red seaweeds | Agar | Galactan | [37] |
Carrageenans | Galactan | [38] | |
Brown seaweeds | Alginate | Mannuronic acid with guluronic acid units | [39] |
Microbial | Xanthan gum | Glucan | [40] |
Cellulose | Glucan | [6] | |
Animal | Chitin | Glucosamine | [41] |
Hyaluronic acid | Glucosamine with glucuronic acid units | [42] | |
Chondroitin sulphate | Galactosamine with glucuronic acid units | [43] |
Plant-based gums are the polysaccharides originated from various parts of plant (e.g. plant cell walls, tree exudates, seeds, tuber/roots, seaweeds) [6]. Most of them belong to the Leguminosae family, which is divided into the subfamilies Caesalpinioideae, Mimosoideae and Faboideae [15]. The polysaccharides sourced from plants are examples of natural compounds that have contributed to the Leguminosae family classification, but special emphasis has been given to galactomannans [16].
The considerably growing interest in gums is due to their diverse structural properties and metabolic functions in food, pharmaceutical, cosmetic, textile and biomedical products [17], since they can be used as dietary fiber, texture modifiers, gelling agents, thickeners, emulsifiers, stabilizers, coating agents and packaging films [6,18]. In the recent years, the demand for plant-based gums in food, medicine and drug delivery systems have been considerably increased because they are the most notable ingredients in liquid and semisolid foods [19]. However, the market still desires new sources of plant-based gum to meet the demand for ingredients with more usefulness especially in food systems [6], hence they are the new generation of products sourced from sustainable materials that intend to comply the ecological and economic requirements.
Acting as soluble dietary fibres, gums play a crucial part in developing foods with high satiating capacity due to their viscosity. Most of the scientific researches mention that when gums are hydrated, they increase the viscosity of the solution medium and show a very wide range of rheological behaviour, generally pseudoplastic, depending on their concentration, chemical arrangement and structure [20].
Studiesdealing with gums as texture modifying agents are continuing to increase in the food and culinary industries, especially for gelling, thickening and emulsifying purposes. Some hydrocolloids are used as gelling agents, for example, to increase the satiety sensation in the stomach, brought about by different triggering factors. It is believed that, in order for gastric gelation to induce satiety, not only must a gel form in the stomach but the gel must also possess some strength [44]. Also as regards the food industry, the most common polysaccharides used for production of edible films are cellulose, chitosan, agar, starch, and no less important, galactomannans, since their mechanical and thermal properties have been widely exploited for biotechnological application.
Not only in food and culinary industry, but also in biomedical applications, the synergistic interactions that occur in systems containing different blends of polysaccharides have been used for a long time due to their ability to form strong gels even at low concentrations [45]. Still in view of the medical field, some of the current challenges in the conventional therapeutic systems include lack of proper drug delivery systems with efficient bioavailability or drug release capability, lack of efficient imaging and sensing technique, lack of targeted delivery systems, etc. As an attempt to circumvent these issues, the advent of nanotechnology allows the use nano-tools to overcome the shortcomings of the conventional methods [46], therefore, natural gums are being processed into various forms, including the most recent nanomaterials, for various biotechnological applications. The main natural polymers, including gums and mucilages, as well as the current researches about them are reviewed below.
Galactomannans are neutral polysaccharides isolated from seeds. The main chain is composed of (1→4)-β-D-mannose (M) units with different degrees of substitution on O-6 with α-D-galactopyranosyl (G) units (Figure 1). Galactomannans are considered highly water soluble hydrocolloids providing highly viscous and stable aqueous solutions, in addition, its solubility depends on the composition (or M/G ratio) and on the distribution of galactose units along the mannan backbone chain: the larger the galactose content, the higher the solubility in water [47].
The M/G ratios varies among the species of the same subfamily. Caesalpinioideae presents M/G ratios ranging from 2.44 (Cassia grandis) [32] to 4.2 (Delomix regia) [48] and its main representatives are Cassia tora (M/G: 3.0) [49], C. spinosa (M/G: 2.7-3.0) [49,50] and Ceratonia siliqua (M/G: 3.5-3.75) [51]. Mimosoideae subfamily presents lower M/G ratios, usually varied from 1 (Mimosa scabrella) [52] to 2.6 (Besmanthus illinoensis) [49]. Faboideae subfamily presents a broad range of M/G ratios for its representatives and includes the main commercially used galactomannan in food and non-food industries, the guar gum (Cyamopsis tetragonolobus, M/G: 1.8) [53].
Galactomannans are polysaccharide gums with several functions associated in terms of their physicochemical and biological properties, which in fact offer a wide variety of applications. Unlike other gums, galactomannans or their derivatives are less exploited on an industrial scale, despite milled endosperm powders of guar, locust bean (Ceratonia siliqua), and fenugreek (Trigonella foenum-graecum)represent the galactomannan seeds currently exploited on an industrial scale [54]. Among their applications, these gums accumulated moisture (desiccation tolerance) at the early stage of seed swelling and serve as a carbohydrate energy resource during seed germination. In addition, galactomannan gums may also play a protective role, since they impart certain strength to the endosperm surrounding the germ at the periphery [55].
Compared with other gums, galactomannans exhibited excellent retention of viscosity even at low concentrations. They can be used as mass-efficient aqueous thickeners, nutritional supplements [11,40], and component in a mixed gel [56,57]. In the food industry, galactomannans as guar and locust bean gum enjoy widespread use based on their ability to thicken and stabilize many food products [55]. More recently, some works reported the possibility of using galactomannans in the formation of films and coatings [14,59,60,61].
In some works, galactomannans have been used in binary mixtures with other polysaccharides such as xanthan gum [62,63,64], agar [65] and kappa carrageenan [58,66], to form gels with new properties. Among the oil and textile industries, galactomannan gums are the major ingredients in drilling mud and are used mainly also for their capacity to increase printing quality. The functional properties of these polysaccharides are of primary importance for controlling the release of drugs in the pharmaceutical industry [67,68].
Cellulose, the major structural constituent of the cell wall of plants, is the most abundant polysaccharide in nature. It has many advantages, such as superior thermal and mechanical properties, in addition to biocompatibility, biodegradability, and cost-effectiveness [69,70].
One of the most successful biomaterials for health is the bacterial cellulose, a promising biopolymer obtained through biosynthesis routes by some bacterial genera belonging to Acetobacter, Rhizobium, Agrobacterium, Aerobacter, Achromobacter, Azotobacter, Salmonella, Escherichia, and Sarcina genera. Bacterial cellulose has been extensively studied due to its purity, superior physico-mechanical and biological properties, as well as its potential applications in numerous traditional industries, such as biomedical, construction, pulp and papermaking, in addition to textile industry [71,72,73].
The biosynthesis of cellulose is a process commonly associated to the living plant cell through photosynthesis. In the oceans, however, most cellulose is produced by unicellular plankton or algae using the same type of carbon dioxide fixation found in photosynthesis of land plants. In addition, several animals, and microbial can assemble cellulose, but these organisms are devoid of photosynthetic capacity and usually require glucose or some organic substrate synthesized by a photosynthetic organism to assemble the polymer [74]. According to Nobles et al. [75], even most cellulose widespread in nature is now being produced by plant cellulose synthase complexes; this enzyme has bacterial origin, therefore its genes have been acquired by plants from cyanobacterial ancestors of their chloroplasts.
Despite the most recent literature dealing with the elucidation of the molecular mechanisms of cellulose biosynthesis in plants, many aspects of this process still remain obscure. Especially for bacterial cellulose biosynthesis, the model system associated with the microbial origin of cellulose has long been used as a simpler and genetically tractable model to study its biosynthesis in plants. Even after this model system became dispensable, studies of bacterial cellulose biosynthesis proved to be extremely important, since bacterial cellulose has advantageous characteristics over comparable with plant cellulose, including high crystallinity degree, elasticity, durability and higher water-absorbance [76,77,78].
In summary, there are four main different pathways to obtain cellulose: the first is the most popular and industrially important pathway for isolating cellulose from plants, which includes the chemical pulping, separation, and purification processes to remove lignin and other polysaccharides (hemicelluloses). The second pathway consists in the biosynthesis of cellulose by different types of micro-organisms (unicellular algae, fungi, and bacteria). The third pathway is the enzymatic in vitro synthesis starting from materials such as cellobiosyl fluoride. The last pathway is a chemical synthesis, that produces cellulose though a ring-opening polymerization of the benzylated and pivaloylated derivatives of glucose [73].
In what concerns the basic structure of cellulose, it is a simple polysaccharide with no branching or substituents in its homogeneous backbone (Figure 2). The morphological hierarchy of cellulose is composed by elementary fibrils, which pack into larger units called microfibrils, and these are in turn assembled into fibres. Within the cellulose fibrils, there are regions where the cellulose chains are arranged in a highly ordered structure (crystallites) and regions that are disordered (amorphous-like). The extraction of the crystalline regions results in nanocrystalline cellulose (NCC), while the interaction between inter-and intra-molecular networks can vary, giving rise to cellulose polymorphs or allomorphs [79,80].
NCC is the base reinforcement unit that strengthen all subsequent structures in plant, trees, etc., and can be a useful material on which to base a new polymer composite industry. NCC has also properties such as low density, high specific strength and modulus, high surface area, unique optical properties, and modifiable surface properties due to the reactive hydroxyl groups [81]. Advantages in the biotechnological application of NCC when compared to macrocellulose are related not only to their useful, unsurpassed, physical and chemical properties, or to their sustainability, biodegradability, renewability, abundance, high biocompatibility. Actually, the nanoscale dimension opens a wide range of possible properties to be discovered. According to Fujisawa et al. [82], NCC can be divided in three major groups: (1) cellulose nanocrystals (CNC), obtained from acid hydrolysis followed by mechanical agitation from the suspension of nanocrystals in water; (2) microfibrillated cellulose (MFC), prepared with mechanical disintegration method of the cellulosic pulp in water; and (3) nanofibrillated cellulose (NFC), prepared using a combination of chemical oxidation with 2, 2, 6, 6-tetramethylpiperidine-1-oxyl (TEMPO), followed by mechanical disintegration in water, or only by mechanical disintegration.
It is important to highlight that the hydroxyl groups are the most targeted reactive groups on the cellulose main chain; they can fully or partially react with chemical agents to obtain various derivatives with different degree of substitution. For upgrading the value of cellulose, the obtained derivatives have been developed and used in industries such as food, cosmetic, biomedical, and pharmaceutical. However, the application of cellulosic material is limited due to the difficulty in processing, for example, the high crystallinity degree and rigid intra/intermolecular hydrogen bonds which result in its insolubility in most solvents [35,83].
The above mentioned problems associated with the processing of cellulose could be observed for other natural polymers since they present increasingly application in the industrial technology. In addition, most polymers do not show biological activity unless some modifications are carried out, so it is important to mention that numerous attempts are being performed to minimize these certain drawbacks with chemical modifications in the polymeric structure.
The most important chemical transformation and functionalization of cellulose based on hydroxyl group include esterification, etherification, selective oxidation, graft copolymerization, and intermolecular crosslinking reaction [84]. The esterification process of cellulose was applied for different purposes, such as the preparation of superabsorbent hydrogels [85] and bacterial cellulose nanofibers [86]. The etherification process of cellulose was especially applied in the pharmaceutical industry, for example to obtain NFC as safe candidate for novel, bio based, and permanently antimicrobial material [87]. The oxidation of primary hydroxyl groups of cellulose is one of the most important methods of their functionalization, which yields valuable oxidized products such as polyuronic acids and aldehydes, to be further used in various fields as drugs, dyes, glues, thickeners, additives to foodstuffs, cosmetics and many other. Oxidized cellulose and regenerated cellulose are widely used as excellent hemostatic materials in various surgical operations and postsurgical adhesion prevention layer [88,89,90].
Regenerated cellulose has also been used as films; cellophane films, for example, have not been commonly used for food packaging, due to their high water vapour permeability (low barrier properties) compared to their synthetic counterparts. On the other hand, transparent cellulose films exhibit good oxygen and CO2 barrier properties at dry conditions. They are made from purified wood or cotton pulp sheets and have important characteristics such as transparency, durability, flexibility, non-water solubility and non-permeability to air and grease. Other transparent cellulose films such as MFC and NFC film have emerged as a potential packaging material due to their strong mechanical properties [91,92].
Currently, there are two oxidation systems to selectively convert the primary hydroxyl groups in cellulose into carboxyl and/or aldehyde groups: (1) 2, 2, 6, 6-tetramethylpiperidine-1-oxyl (TEMPO) and its derivatives; (2) N-hydroxyphthalimide (NHPI), N-hydroxy-benzotriazole (HBT), and violuric acid (VA) [93,94]. The amount of carboxylic groups formed by oxidation of cellulose was investigated for different and important purposes, such as the following examples. A comparatively investigation between TEMPO and NHPI to oxidize regenerated cellulose fibers [95], the potential of TEMPO-mediated oxidized NFC as bioremediator of metal ions from contaminated water [96]; the in vitro antibacterial evaluation of TEMPO-oxidized cellulose films functionalized with silver nanoparticles [97]; and the preparation of water stable films made of TEMPO/NaClO2 oxidized NFC, covalently bonded with poly(vinyl alcohol) [98].
Another approach for cellulose modification via chemical redox initiation methods (ceric ammonium nitrate or ferrous ammonium sulphate-potassium persulfate) or irradiation methods (UV, microwave, andγ-rays) is the graft copolymerization, which provides a mean of altering the physical and chemical properties of cellulose and increasing its functionality [35,97,98,99,100,101].
Nowadays, the research on cellulose nanocomposites has grown exponentially. As definition, cellulose nanocomposites are structures composed of water-soluble or water-dispersive polymers mixed with cellulose nanomaterials, and manufactured using different processes able to affect properties such as dispersion, distribution and alignment of the reinforcing phase of the composite [102]. The most recent literature dealing with cellulose nanocomposites described the employment of the microwave-assisted method on the investigation of the influence of cellulose on nanocomposites of cellulose/Ag [103], cellulose Ag/Cl [104], cellulose/SrF2 [105], cellulose/CaF2 and cellulose/MgF2 [106], and cellulose/F-substituted hydroxyapatite [107]. The pharmaceutical field has important studies, for example, all cellulose nanocomposite membranes with excellent performance were successfully fabricated as novel filtration system to remove nanoparticles and Hepatite C virus from aqueous medium [108]. Transparent porous nanodiamonds/cellulose nanocomposite membranes with controlled release of doxorubicin were tested as a candidate for wound dressing [109]; and cellulose-graft-polyacrylamide/nano-hydroxyapatite composites were reported as a promising scaffold for bone tissue engineering [110,111].
Glycosaminoglycans (GAGs) are heteropolysaccharides composed by a repeating disaccharide unit without branched chains, being one of the two monosaccharides always an amino sugar (N-acetylgalactosamine or N-acetylglucosamine) and the other one an uronic acid. They are usually found on all animal cell surfaces and in the extracellular matrix, where are known to bind and regulate different proteins. In the last years, an increasing number of GAGs, chitin and chitosan applications have been reported by the scientific literature reporting their applicability in numerous contexts from food, cosmetic, textiles and clinical areas [43].
Chondroitin sulphate (CS) is an essential component of extracellular matrix of connective tissues in which plays a central role in various biological processes, including the elasticity of the articular cartilage, hemostasis and inflammation, regulation of cell development, cell adhesion, proliferation and differentiation [43]. Hyaluronic acid (HA) is classified as a viscous substance with multifunctional properties, especially those related to biological functions like cell proliferation, differentiation and tissue repair; the applicability of HA has been focused recently as drug delivery devices with studies suggesting a number of molecules might be used as gel preparations for drug transport. Since the application of the polysaccharide in the medicinal field has been increased, the interest in isolation of HA has been augmented to greater extents [112].
Although CS and HA has been isolated from terrestrial origin so far, the increasing interest on these polysaccharides significantly aroused the alternative search from marine sources since it is at the preliminary level. However, chitin is still the main waste product of the shellfish industry and, due of this importance, will be detailed revised below.
Chitin
Chitin is the second most abundant polymer after cellulose [89]. Its chemical structure (poly-β-(1→4)-N-acetyl-D-glucosamine) is widely synthesized in a number of living organisms, which depending on its source, chitin occurs mainly as two allomorphs, namely α (the most abundant) and β forms [47]. Sharing the classification of natural polymers from animal origin with CS and HA, chitin can be found in many organisms including fungi, yeasts, algae and squid pen; it is also usually found in lobsters, crab tendons, shrimp and crab shells as well as insect cuticles, being shells the preferred source of chitin due to their high availability as waste from the seafood processing industry [43,47].
Chitin occurs in nature as ordered crystalline microfibrils found as structural components in the cell wall of fungi and yeast or in the exoskeleton of arthropods. The main commercial sources of chitin are crab and shrimp shells, where chitin is associated with proteins, pigments and calcium carbonate. The physical properties of chitin in solution are still scarce in the literature due to the difficulties in dissolving the polymer; chitin is insoluble in all usual solvents, which represents a problem in view of the development of processing and of its uses [47].
Chitin can be partially degraded by acid to obtain a series of oligomers namely oligochitins. Instead, under alkaline conditions, a partial deacetylation of chitin results in the most important chitin derivative in terms of applications: chitosan (Figure 3). Oligochitins as well as those from chitosan are recognized for their bioactivity including antitumoral [113,114], antimicrobial [115], fungicidal [116] and immunotherapeutic [117] properties, eliciting chitinase [118], and regulating organism growth [111].
Chitin is an amino polysaccharide having massive structural propensities to produce bioactive materials with innovative properties, functions and a range of biotechnological applications. In addition, the specific physicochemical, mechanical, biological and degradation properties offer efficient way to blend this biopolymer with synthetic ones [119].
Chitin has a low toxicity and it is inert in the gastrointestinal tract of mammals. Chitinases and lysozyme from egg white can degrade chitin; in the first case, the enzymes are widely distributed in nature, found in bacteria, fungi and plants as well as in the digestive tract of numerous animals. After the deacetylation process, it was shown that the rate of in vivo degradation is high for chitin, but decreases for chitosan [47,120].
The main applications of chitin are in medical and pharmaceutical fields, especially due to the presence of the acetamide group, which is similar to the amide bond of the protein of the living tissue and, therefore, is compatible with human or animal cells. Hence, chitin can be used in wound healing [121,122] and tissue engineering applications [123,124].
Still in view of wound dressing materials, Morgado et al. [125] remarked that chitosan had also been used for wound dressing production due to its intrinsic properties, including antimicrobial and hemostatic activities, biocompatibility, and biodegradability. Chen et al. [126] and Lih et al. [127] also highlighted the potential application of chitosan as wound dressing due to the recognition of its surface by platelets. The coagulation cascade starts in a few seconds with the protonated amine groups of chitosan attracting the negatively charged residues on red blood cell membranes, resulting on a strong agglutination, thrombin generation and fibrin mesh synthesis within the microenvironment created by this polysaccharide.
The marked insolubility of chitin in all usual solvents is the most different property compared to chitosan, which is the only commercially available water-soluble cationic polymer due to the positive charges on its amino groups. The water solubility of chitosan allows the interaction of this cationic biopolymer with anionic molecules such as glycosaminoglycans (GAG) and proteoglycans. Many cytokines/growth factors are linked to GAG, so the complex of chitosan-GAG may retain and concentrate those substances [128]. This unique property makes chitosan an appropriate material not only in the biomedical and pharmaceutical fields; instead, the antimicrobial and gas barrier properties of chitosan were successfully applied in the food industry, for example, in a nanomultilayer coating obtained by electrostatic layer-by-layer self-assembling technique; by combining the intrinsic properties of chitosan and the low oxygen permeability of pectin, layers were efficient in the reduction of gas flow and on the extension of the shelf-life of mangoes [129]. Chitosan-based films with quercetin incorporated also showed potential to be used as a solution for active food packaging [130]. The positive charge of chitosan was also used in the development of a high-efficient gene delivery formulation combined with polyethylenimine and DNA by Min et al.[131], who achieved a system less cytotoxic than those made of a single cationic carrier.
Many applications were described based on chitin and its blends for tissue engineering, for example, Wan and Tai [132] presented a revision of chitin as scaffolds and matrices for tissue engineering, stem cell propagation and differentiation. Polymer matrix-calcium based composites were used for hard tissue substitutes [133], in addition to drug delivery [134]. Chitin is also efficient to give porous forms providing scaffolds for complete tissue formation [135,136].
In what concerns drug delivery system, chitin and its derivative amorphous chitin, alone or with other polymers, have been widely used due to its biocompatible, biodegradable and non-toxic nature [137]. Further, more recently application takes into consideration the high surface area presented in nanometric systems, especially because of the nano-size possess certain unique properties which enable them to be used in a number of biomedical applications. Prepared by cross-linking reaction using TPP, chitin nanoparticles were described as efficient networks for drugs with antitumoral [138,139] and antibacterial [137]purposes. Working with one derivative of chitin containing carboxyl groups (CMC), Dev et al. [140] have taken the approach of cross-linking the CMC as a way to control its biodegradability and to result in nanoparticles, providing a most favorable option for drug delivery applications in chemotherapy. Chitin nanoparticles can be also isolated from the purified chitin by repeated acid hydrolysis and applied for different purposes, such as the development of bio-nanocomposites with starch [141] and as a suitable adsorbent material for the removal of dyestuff from effluents [142].
Chitin can be used in the food industry because of its biological activities including antioxidant and antimicrobial effects. In addition to other properties that could improve food safety, quality, and shelf life [143], however the main publications dealing with protective barrier against food spoilage [144,145], edible film production [146,147,148,149,150], use as stabilizers and thickeners compounds [143], and prebiotics ingredients [151] related chitosan as the most efficient biomaterial in this field.
Algae are an important source of many polysaccharides from the point of view of applications, in addition to be the oldest known living organisms. Morphologically, they are very primitive and their evolution was very slow over time. Blue-green algae (Cyanophyta) appeared first, followed by red algae (Rhodophyta), green algae (Chlorophyta) and finally brown algae (Phaeophyta). Algae are in fact rich in non-essential and essential amino acids such as proline, glycine and lysine, besides many other molecules [39,47].
It was recognized that the three main gums, agar, alginate, and carrageenan, could be extracted from algae and used especially as thickeners or gelling polymers. Their physical properties are efficiently used in food, however new applications of algae are being developed, for example in the production of drugs and pharmaceuticals. Red seaweeds contain agar (mainly neutral), carrageenans and a few other polysaccharides included under the category of sulphated polysaccharides. Brown algae produce alginates, a carboxylic polymer, initially in different ionic forms and a few other polysaccharides, among them fucoidans [47].
Algae derived from Rhodophyta are an important source of polysaccharides, which are sulphated glycans together with a variety of O-methylated sugar residues, among them carrageenans and agars, polysaccharides commonly used in industry. The basic structure of these polymers is composed of a linear chain ofβ-D-(1→3) galactopyranose andα-D/L-(1→4) galactopyranose units (Figure 4) arranged in an alternating sequence [47].
Polysaccharides sourced from red algae have attracted an increasing interest due to their excellent physical properties, such as thickening, gelling, and stabilizing ability [152,153], and also due to their beneficial biological activities, such as anticoagulant [154], antithrombotic [38], antioxidant [155], antiviral [156,157], anti-inflammation [158], antitumour [159], and immunomodulatory activity [160]. It is important to highlight that their biological activities depend on the structural features, such as the sulphate content and distribution of sulphate groups on the main chain, molar mass, and stereo-chemistry.
Agar is a gelatinous substance composed of alternating D-and L-galactopyranose units. Its macromolecular structure consists in a mixture of agarose and agaropectin. Agarose is the neutral fraction of agar, and it is obtained by precipitation of the anionic agaropectins by quaternary ammonium salt and separation by centrifugation. Agaropectin is a heterogeneous mixture of smaller molecules, which have similar structures with agarose but contains many anionic groups such as sulphate, pyruvate and glycuronate. Due to the similar chemical and physical properties with agarose, agar has also been widely studied and applied in the biomedical field because of its good biocompatibility, biodegradability, nontoxicity, availability and lowcost [47,161].
Agarose adopts a single or double helical conformation in the solid state. Gelation occurs by aggregation of double helices at a temperature dependent on methoxyl and sulphate contents, which can modulate this process. The three-dimensional network based on association of double helices is thermoreversible, i.e., the crosslinks occur physically without chemical catalyst or any crosslinking agent, and it is stabilized by cooperative hydrogen bonds. Therefore, the low cost, special mechanical properties, biocompatibility and relatively bioinert nature make agarose a promising alternative as a gel matrix [47,162].
Since agar and agarose have good biocompatibility and excellent moisturizing capacity, many applications were described in the literature. Various forms of systems based on agar and agarose have been developed for the applications in pharmaceutical industries and medical research: Miguel et al. [163] produced a new in situ thermo responsive hydrogel composed by agarose and chitosan to be used as an injectable scaffold for tissue regeneration. They corroborated Varoni et al. [164], who described agarose hydrogels as mouldable materials, i.e., the hydrogel may be polymerized in situ reducing invasiveness of the surgery, besides it also be able to acquire the right shape at the wound site, without wrinkling or fluting and interacting with the damaged tissue. Agar and agarose fibers were fabricated by Bao et al. [161] and demonstrated to be good candidate materials for wound-dressing applications.
The scientific literature reported that the use of hydrogel as biomaterials for wound healing is also promising, however, they usually exhibit relatively poor mechanical properties due to the high swelling ratio, which limits their practical applications as wound dressings. Therefore, the most recent studies demonstrated that the incorporation of nanomaterials is probably the effective strategy to improve the mechanical property of hydrogels [165]. Wang et al. [166], for example, developed nanocomposite hydrogels based on agarose and ZnO and concluded that the system might be an excellent candidate for wound dressings.
Agarose can be processed by extrusion from solution at high temperature, forming gel beads into ice-cold buffer. Another method is to emulsify agarose in a warm fluid which is immiscible with the aqueous polysaccharide solution; the emulsion is then cooled and produce microspheres [167]. Large-sized agarosebeads can be prepared by some typical techniques, such as mechanical stirring and spraying methods. However, these methods suffer from poor control of droplet size and size distribution, low energy efficiency, and time consuming characteristics. Li et al. [168] improved the emulsification reproducibility and stable bead properties by developing a manufacturing protocol for uniform droplets and beads of controlled size with rotating membrane emulsification.
Agarose is also widely used as growth medium for microorganisms (bacteria and fungi) [169,170,171] and for biotechnological applications. Agarose was submitted to an enzymatic hydrolysis process with no acid treatment and converted in a potential hydrolysate for bioethanol production [172]. By casting and subsequent drying process, agar and agarose films can be formed depending on the application [173,174].
In the food industry, it is well known that agar films possess several properties adequate for food packagingapplications, however, their high cost-production and quality variations caused by physiological and environmental factors affecting wild seaweeds make them less attractive for industries [175]. Despite having good mechanical and relatively good oxygen and water barriers properties, the most recent trends in food industry use nanomaterials as promising option to improve mechanical and barrier properties of biodegradable agar-based composite films [176,177,178].
In the domain of blends, agar was mixed with different materials, for example, poly(vinyl alcohol) and soy protein, respectively for specific food applications [179] and for scanning the variations in the matrix tensile strength [180]. Agar and agarose were also mixed with different polysaccharides to produce blends with potential biotechnological applications. Agarose was mixed with fenugreek galactomannan and formed a matrix efficiently used as biosensor to detect pesticides in food [181]. Multicomponent hydrogel films composed of agar, κ-carrageenan, konjac glucomannan powder, and nanoclay improved mechanical and water resistant properties of the blended hydrogel film [182]. Recently, agarose blends have been used in nanotechnological process, such as the rheological study of agarose hydrogels with tunicate cellulose nanowhiskers [183].
Carrageenan is a word that seems to originate from the inhabitants of the country of Carrageen, on the south Irish coast where extracts from red algae for food and medicines were already used as early as 600 years ago. The major constituent of such algae is the so-called carrageenans, naturally occurring anionic sulphated linear polysaccharides with the linear backbone built up byβ-D-galactose and 3, 6-anhydro-α-D-galactose with variable density in the sulphated group [38,184].
There are several different carrageenans with slightly varied properties and chemical structures. The three most prevalent and of highest commercial interest are called iota, kappa, and lambda carrageenan, differentiated based on the amount and position of sulphate groups, and serving different properties [38].
Carrageenans have been extensively used in the food industry as thickening, gelling, stabilizing and protein-suspending agents due to its biocompatibility, biodegradability, high capacity of water retention and mechanical strength of its gels.According to the properties of carrageenan, it can split into two groups like, gelling (kappa and iota) and thickening agent (lambda); the 3, 6-anhydro-α-D-galactose is essential for the gelling properties of kappa and iota carrageenans. The molecular weight of carrageenans is critically important to its functionality in food, so, as stabilizers, carrageenans achieve its functionality due to its high molecular weight and binding capacity to proteins through charged sulphate and carboxyl groups [185].
The most recent applications of carrageenans are described in the following. Encapsulation ofβ-galactosidase in kappa carrageenan hydrogel beads was investigated for the application in food industry [186]. Multilayer coatings composed of kappa carrageenan and chitosan were produced, characterized in terms of their permeability’s and surface properties [187], and used as model for the release behavior of Methylene blue; the industrial relevance of this type of nanolayered coatings consists in the development of bioactive compound release systems for application in food industry [188]. Multilayer films with a nanocomposition of kappa carrageenan, agar, clay and polylactide were prepared to modify the mechanical and barrier properties of the film for the food packaging application [189]. Still in view of the nanoscience, carrageenans were used not only as carriers of active antimicrobial nanoparticles, but also as polymer matrices for biodegradable films, for example, nanocomposite films with carrageenan, silver nanoparticles and clay mineral were prepared to test their combined effect on the antimicrobial activity and physicochemical film properties [190].
The biologicalactivity of carrageenan as a natural occurring gum has been increasing widely for human applications and creates a strong position in the biomedical field [38], but it is important to highlight that the preliminary studies reported carrageenans administered in drinking water or diet could be a potential cause of intestinal inflammation and ulcers in animals [38,191]. Later, it was determined that these studies and others were conducted with a different material obtained by a degradation of the carrageenan that resulted in a sulfated polysaccharide with the same structural backbone to carrageenan, but with a lower molecular weight and different functional properties. Degraded carrageenan is referred to as poligeenan [185,192], polymer obtained by acid hydrolysis at high temperatures for several hours [185,193]. Poligeenan is also used in food applications, however, it was related to capable of causing gastrointestinal irritation in experimental animals and was considered to cause gastrointestinal cancer in animals. Carrageenans do not cause these effects and is safe at maximally administered oral doses [185]; they are related to inflammation just as employed in laboratories to create pathological models for exploration of the process and treatment of the inflammation [194,195,196,197,198].
Regarding the biological activities of carrageenans, its effect as food supplement was investigated on the immunity status and lipid profile in patients with cardiovascular disease. The results demonstrated that carrageenan moderately modulated all of the immunity system markers, caused statistically significant decreases in important biomarkers of chronic inflammation and significantly decreased cholesterol levels and low density lipoprotein cholesterol [199]. Besides the well-known biological activities related to inflammatory, immune [200], antioxidant [201,202,203], and antitumor responses [204,205], carrageenans are potent inhibitors of herpes and HPV viruses and there are indications that these polysaccharides may offer some protection against HIV infection [38,200].
Anticoagulant activity could be the most attractive property associated to carrageenans [154,160,206] and also to other sulphated polysaccharides, which were reported to possess similar or even stronger activity than those of heparin.
Carrageenans have been used by the pharmaceutical industry as excipient in different forms of presentation. Hydrogels of kappa carrageenan containing CaCO3 and NaHCO3 were tested as pore forming agents by Selvakumaran and Muhamad [207], and the system with CaCO3 was considered an efficient floating drug delivery system for amoxicillin trihydrate. Iota-carrageenan was investigated not only as a drug-loaded polymer but also as an ionic polymer to increase the solubility of the lappaconitine analgesic-alkaloid [208]. Hydrogels composed of kappa carrageenan and synthetic or natural polymers were reported, such as the blend constituted of kappa carrageenan and polythiophene for the electrically controlled drug release of acetylsalicylic acid [209]. Carrageenans were also used by the Interpenetrating Polymer Network (IPN) technique, which possess several advantages like high swelling capacity and tremendous mechanical strength on the targeted and controlled drug delivery. For example, IPN beads of kappa carrageenan and sodium carboxymethyl cellulose using AlCl3 as a crosslinking agent were evaluated on the drug release behavior of ibuprofen [210].
Alginate is the most important polysaccharide derived from brown algae (Phaephyta), and it can be also produced by soil bacteria (Azotobacter vinelandii and Pseudomonas species). This gum is composed of 1, 4-linked β-D-mannuronic acid (M) with 4C1 ring conformation and α-L-guluronic acid (G) with 1C4 conformation, both in the pyranosic conformation and present in varying amounts. It was demonstrated that the physical properties in aqueous medium for these polymers depend not only on the M/G ratio, but also on the distribution of M and G units along the chain. In addition, the stiffness of the alginate chains as well as calcium complex formation could be attributed to the composition (M/G ratio) and distribution of M and G units in the chains [47].
The main property of alginates is their ability to retain water, in addition to gelling and stabilizing properties. Because of their linear structure, and high molecular weight, alginates form strong films and good fibres in the solid state. Gel formation is a very important characteristic for alginates; the higher content of G units form stable crosslinked junctions with divalent counterions (for example, Ca, Ba, and Sr, unless Mg), so the crosslinked network can be considered a gel (Figure 5). In addition, the low pH also forms acidic gels stabilized by hydrogen bonds [47].
As an anionic polymer, alginate forms electrostatic complex when mixed with a cationic polymer. The stability of the formed complex depends on the pH and salt concentration, but even in the best conditions, the complex is insoluble and thus allows the formation of fibres, films, and capsules. Many applications are proposed to these complexes, especially for the most investigated polyelectrolyte complex based on alginate and chitosan. For example, a nanomultilayer coating composed of sodium alginate and chitosan, obtained by electrostatic layer-by-layer self-assembling, onto aminolyzed/charged PET was characterized and presented highly functional properties and promising future for industrial applications [211]. This alginate-chitosan nanomultilayer coating was applied in fresh-cut mangoes and improved the microbiological and physicochemical quality, extending the quality and shelf life of fresh-cut mangoes up to 8 days [130]. The deposition of functionalized particles on multilayers based on chitosan-alginate was investigated with the aim to use the complex in opto-electronics, biosensors or medical applications [212]. Belscak-Cvitanovic [213] prepared chitosan-alginate beads to encapsulate and retard the release of caffeine in water. Wang et al. [214] developed chitosan-alginate coatings to deliver titanium substrates via electrodeposition and suggested the potential application of this composite coating in tissue engineering scaffolds field. One more example is the study of Seth et al. [215], who designed magnetic chitosan-alginate core-shell beads for oral administration of low permeable drug.
Several studies have shown that the chitosan-alginate complex acts as an effective way to improve de stability of encapsulated compounds [216,217]. It is important to highlight that, nowadays, the most extensively investigated delivery systems to encapsulate, protect and control the release of functional and unstable compounds in industries varying from food to pharmaceutics considers the development of capsules in micro and nano scales. Liu et al. [218] optimized a formula of chitosan-alginate deposited nanoliposomes and observed an improved in vitro digestion stability. Haidar et al. [219] developed core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes and demonstrated that the polymers shell could increase the membrane stability and sustain release of the model protein. Liu et al. [220] evaluated the environmental stress stability of microencapsules based on vitamin C liposomes decorated with chitosan-alginate membranes and observed the release kinetics of these formulations during in vitro gastrointestinal digestion. Chitosan-alginate complexes loaded with other nano compounds were tested with different purposes, including bactericidal activity [221], tissue engineering [222], and osteochondral [223] and food [224] applications.
Other polyelectrolytes may also be involved to form complexes with chitosan-alginate, such as collagen [225], gelatin [226], inulin [227], BSA protein [228], poly(L-lysine) [229], poly(L-lactide) [230], and hydroxyapatite [231].
Regarding the characteristic advantages of alginates, including biocompatibility, biodegradability, immunogenicity, and gel formation, alginates are well adapted for biomedical and pharmaceutical applications, such as tissue engineering, delivery vehicles for drugs and cell or enzyme entrapment. In addition, alginates have been successfully used in the food industry, for example, to prolong shelf life of the products and protect bioactive compounds encapsulated in the alginate matrix [232,233]; they can also be used as an antioxidant active interface for food preservation [234], and as a part of matrices designed to improve the oxidative stability during food storage [235].
Taking into account the above mentioned characteristics of alginates, nearly all of them are harvested in their wild state; cultivation is too expensive to provide alginates at a reasonable price for industrial applications. The quantity and quality of the alginates extracted depend on the algae species and on the season of harvest; furthermore, the higher content of alginate is still directed to the food industry.
Cashew gum (CG) is an exudate extracted from Anacardium occidentale, a popular tree belonging to the family Anacardiaceae. The cashew tree can grow up to 12 feet tall and is native to northeastern Brazil, however it can also be found in India, Mozambique, Tanzania, Kenya and among other countries. As a polysaccharide exudate, this gum is produced as a mechanism of plant defense against stress caused by physical injury or microbial attack. Its production can occur in all parts of the tree and its qualitative and quantitative depends on tree maturity and environmental conditions; initially, the gum is off white in colour but changes to reddish brown or yellowish brown on exposure. It is sparingly soluble in water but swells in contact with it giving a highly viscous solution [236,237,238].
The polyuronide CG is composed of a branched framework of D-galactose units. In addition, present are D-glucuronic acid, L-arabinose, L-rhamnose and, except in the case of a Venezuelan sample, D-glucose. D-xylose, D-mannose and 4-O-methyl-D-glucuronic acid have been found in some samples [239,240]. As a mixture of acid polysaccharides, CG contains various metal ions such as neutralized cations. The nature and content of these constituents depend on the composition of the soil upon which the trees grew. The major cations of A. occidentale are K+, Na+, Ca2+ and Mg2+. Crude CG, containing these cations, tends to be naturally transformed into Na+ salt, after purification or dialysis against NaCl 0.15 M, as previously described [237,239]. Figure 6 demonstrates the chemical composition of the galactose framework of CG and a graphic representation of the sugars and cations possibly associated to the polysaccharide.
CG, as a versatile, naturally occurring biopolymer, is finding increasing applications in biotechnology industries, especially from pharmaceutical to food industry; however, there is a lack of understanding of its physicochemical properties thus limiting its applications. Chemical structure, solubility and molecular weight of CG closely affect its solution properties as well as its interactions with other polysaccharides [239].
Modifications of gums have been tried through derivatisation of functional groups, grafting with polymers, cross-linking with ions, etc. The modification of CG can improve its technological and functional properties, since its application is related to a better understand on the physicochemical properties of the gum, in its original state or chemically modified, either isolated or blended with other polymer [241].
The unique properties of CG are due to hydroxyls, the majority, and to carboxyl reactive groups. This polysaccharide is easily chemically modified to reduce the water solubility or to develop pH sensitivity, introduce functional reactive groups, etc. Therefore, it can be utilised for a chosen application [237]. Thus, as the composition and properties of CG were disclosed, the chemical modification observed for blends composed of CG and other polymers were proposed to increase their reactivity. Following the use of CG blended with other polymers, the most recent literature reports the development of systems for drug release, like microbeads [242] and nanoparticles [243] of CG and alginate, and nanogels of CG and chitosan [244].
Several applications of blended CG were described, such as the production of films prepared with CG and polyvinyl alcohol (PVA) with the important purpose of wound therapeutics [245,246]. A layer-by-layer film containing CG intercalated with polyaniline unmodified or modified with phosphonic acid intercalated with CG was evaluated in determination of dopamine [247], and nanocomposite films of starch and CG were added to a nanoclay to increase the stability of cashew nut kernels [248]. Hydrogels based on CG (namely Policaju in this study) and chitosan were developed, characterized in their chemical structure, and indicated as a promising road to biomaterial fabrication and biomedical applications [249]. The larvicide activity of an essential oil loaded in beads based on chitosan and CG was evaluated by Paula et al. [250]; afterward, CG nanoparticles added with other essential oil was proposed to improve the controlled release of a larvicide system [251]. CG and carboxymethylcellulose based formulations have been evaluated as protective edible coatings on intact and cut red guavas [252].
The properties of CG have also been exploited as a binder, for example the binding efficacy of CG based on tablet formulation was investigated in comparison with standard binders such as acacia and polyvinyl pyrrolidone; the results suggested that CG can be used as an alternative binder to produce a tablet of better mechanical strength and dissolution profile of particular drug substance [253]. In addition, CG can be used as a substitute for liquid glue for paper, in the cosmetic industry, as an agglutinant for capsules and pills [237], and as edible coatings for application on mangoes [27] and apples [254].
Fabrication of systems utilizing CG for drug delivery have been an area of great interest, such as the transdermal release profile for diclofenac diethyl amine loaded with nanoparticles of acetylated CG [255].Other example is the study about the controlled delivery of antimicrobial peptides immobilized in multilayer films of CG and indium tin oxide to combat and prevent anti-leishmanial activity [256]. Self-assembled nanoparticles from hydrophobized CG containing an anti-inflamatory drug was also characterized as a drug delivery device [257].
CG is one of few biopolymers that have been proposed to replace the similar but more popular polysaccharide gum arabic. As a biopolymer with amphiphilic compounds, CG was reported to have about 6% of polysaccharide-protein complex, suggesting that probably the same complex is present in the gum arabic. The similarity of both gums suggests the study of CG in the food and beverage industry as thickening and gelling agent, and as colloidal stabiliser [258].
Pectin is a complex and heterogeneous polysaccharide located in the middle lamella and primary cell walls of plant tissues, and in fruits and vegetables. The chemical structure of pectin depends on the origin, location in the plant and extraction method, been composed of acidic polymers, known as homogalacturonan, rhamnogalacturonan and xylogalacturonan with several neutral sugars/polymers such as arabinans, galactans and arabinogalactans (attached as side chains). The available data support the highly schematic model of pectin shown in Figure 7. The backbone containsα-(1-4)-linked linear homogalacturonic units alternated with two types of highly branched rhamnogalacturonan regions. The first region is substituted with side chains of arabinose and galactose units, while the second has a highly conserved structure, consisting of the main chain branched with eleven different monosaccharides, including some rare sugars such as 2-O-methylxylose, 2-O-methylfucose, apiose, aceric acid, 2-keto-3-deoxy-d-manno-octulosonic acid, and 3-deoxy-d-lyxo-2-heptulosaric acid. Xylogalacturonan is similar to homogalacturonan except that it is substituted with singleβ-(1-3)-xylose units or such units substituted with a few additionalβ-(1-4)-xylose. In all natural pectins, some of the carboxyl groups exist in the methyl ester form [35,47,259].
Pectin has a high molecular weight and can be converted into hydrogels, intended as flexible network of polymer chains that can swell but do not dissolve in water. Pectin solutions at high concentrations and low pH facilitate the formation of coil entanglements, resulting in formation of physical gels. Moreover, water-insoluble gels may be obtained with the use of divalent or trivalent cations. This simple gelling mechanism has raised interest for the preparation of hydrogels for biomedical applications, including drug delivery, gene delivery, tissue engineering and wound healing. It is also important to highlight that the monosaccharide content and the spatial disposition of the crosslinking blocks in the pectin structure need to be carefully considered when designing pectin gels for specific biomedical applications [260].
Pectins exist with different degrees of esterification. They can be classified as high methoxyl pectin or low methoxylpectin according to its degree, that yield some differences in their properties, for example, pectins with a high degree of esterification form thermoreversible gels in acidic conditions [47,261].
Pectins are widely used as technological adjuvants in the food industry, fully exploiting their structural diversity. Different structures lead to distinct gelling properties, emulsion and thickening activities, emulsion stabilities, and release effects in complex food matrices. In the pharmaceutical industry, pectin is commonly used as an excipient due to its non-toxicity, low production costs, and gelling activity properties [262].
Edible coatings based on pectin [263,264] and associated with other polysaccharides, including alginate [265] and chitosan [129], were developed in terms of evaluate the coating storage ability on foods and fruits. Pectin containing agricultural by-products are also used as potential sources of a new class of prebiotics known as pectic oligosaccharides [259,266,267]. The impact of protein content and combination mode between protein and pectin on emulsifying properties is one of the most properties studied by the scientific literature [268,269,270].
The increasing use of pectin in drug delivery is facilitated by the physicochemical properties of pectin. Muco-adhesiveness, ease of dissolution in basic environments, resistance to degradation by proteases and amylases of the upper gastrointestinal tract and the ability to form gels in acid environments, which allows this natural polysaccharide to target different drug delivery formulations. For example, films [271], beads [272], pellets and structures in micro and nanoscale [273,274,275], into completely different environments such as nasal, vaginal, ocular, gastric and, specially, large intestine [261,276]. The use of pectin-derived drug carries in colon cancer treatments has been extensively considered; pectin is intact in the upper gastrointestinal tract and degraded by specific colonic bacteria [277,278]. Modification of pectin via grafting with poly(N-vinylpyrrolidone) (PVP) has also been reported to form an effective hydrogel that can make effective colon-targeted drug delivery [279]. In terms of the gel-forming capacity, pectin lowers cholesterol by binding the cholesterol and bile acids in the gut, thus promoting their excretion [280,281,282].
In addition to food and pharmaceutical applications, recent studies reported that pectins showed immunomodulating activities [283,284,285]. The hydrogel of pectin has been explored in tissue engineering applications for bone cell culture and promoting the nucleation of minerals, and in wound healing applications for binding active drugs or growth factors and protecting against bacteria [260]. Still in view of the wound care, oxidized pectin and carboxymethyl chitosan membranes were developed by in situ cross-linking and demonstrated to be non-hemolytic and cytocompatible [286]. Pectin is a natural anti-glycation agent and has been used beneficially to treat healing damages. Wound dressings of oxidized pectin, gelatin and nonwoven cotton fabric were used as immobilizing supports for nanosilver and ciprofloxacin [287] and alow vera and curcumin [288] with the important propose to test their viability as effective materials for wound management.
Starch is a biopolymer synthesized in a granular form by green plants for energy storage over long periods. Starch granules consist of two major components, branched amylopectin and linear amylose; in both cases, the basic structure is composed ofα-D-glucopyranose residues, formingα-1, 4-glucosidic bonds in linear structure of amylose and additionalα-1, 6-glycosydic branches in amylopectin molecules. Minor constituents such as lipids, proteins, and minerals are present in starch and the levels vary with the origin. The differences in structure of amylose and amylopectin have indeed significant variance in their properties. Amylose is much more prone to crystallization process, called retrogradation, and can produce tough gels and strong films, while amylopectin could be dispersed in water and retrogrades much slower, which results in soft gels and weak films [35,289].
The predominant model for starch structure is presented in multi-scale, consisting of granules, into which is found growth rings composed of amorphous and crystalline lamellae containing amylopectin and amylose chains [290], as can be observed in Figure 8.
Starch is an excellent material for biotechnological applications due to its non-toxic, renewable and biodegradable characteristics; however, its direct applications are limited by its poor processability and intrinsic properties, such as thermal, mechanical, and biological properties. Thus, various chemical, physical, and enzymatic modifications or blending with other materials has supplied solutions to achieve properties that are more desirable. Similar to the cellulose (section 4), conventional chemical modifications of starch are performed based on the primary and secondary hydroxyl groups, including esterification, etherification, oxidation, and graft copolymerization [35].
Starch esters are generally prepared by reacting with fatty acids and fatty acid methyl ester in organic solvents [291,292]. Starch esters have been developed for pharmaceutical applications, e.g. used as superdisintegrant and matrix former in capsules and tablet formulations; and for medical application to maintain human colonic function and preventing colonic disease [35,293].
Quaternary ammonium cationic starches, the major commercial starch ethers, are commonly prepared by the reaction of an aqueous alkaline solution of 2, 3-epoxypropyltrimethyl ammonium chloride or 3-chloro-2-hydroxypropyltrimethyl ammonium chloride. The quaternary ammonium-substituted cationic starches may form nanoparticles with anionic sodium tripolyphosphate. The nanoparticles could entrap hydrophobic molecules, providing a great potential as nanosized carrier in health care and environmental sciences [35,294]. Hydroxyethyl starch is semisynthetic starch ether by reacting with ethylene oxide in alkaline medium, and it has been used as a plasma volume expander and cryoprotectant in medicine. A nanocarrier based on hydroxyethyl starch for active receptor-mediated targeting was synthesized [35,295]. The hydroxyethyl starch folic acid conjugate nanocarriers could be of high interest for the development of receptor mediated targeting using polymeric nanocapsules to deliver and accumulate their encapsulated molecules to the targeted area.
Selective oxidation of starch with N2O4 or a TEMPO/NaClO/NaBr system can exclusively yield carboxylates on the primary hydroxyl groups. Such oxidation approaches can also be applied to selectively oxidize starch derivatives, which bear another oxidation candidate primary hydroxyl group (e.g. hydroxyethyl starch) [35]. Recently, NaClO oxidation was applied in the aqueous re-dispersibility of starch nanocrystal powder and increased the oxidation degree from 0.41 to 0.581% (w/w), while the applied active chlorine increased from 1 to 4% (w/w) [296].
It is important to note that starches are chemically and/or physically modified to accentuate their positive characteristics, diminish their undesirable qualities (such as high viscosity, susceptibility to retrogradation, and lack of process tolerance), or improve new attributes (retention, film formation, digestibility, solubility, etc.). Acid hydrolysis has been used for a long time to modify starch and its properties because of its simplicity and controllability; recently, the main researches about acid hydrolysis has been applied for preparing starch nanocrystals (SNC). The preparation methods and applications of SNC have been extensively reported by the scientific literature [290,297,298,299,300]. In addition to SNC, starch crystallites, microcrystalline starch and hydrolysed starches all refer to the crystalline part of starch obtained by hydrolysis. They differ from each other in the extent of hydrolysis they have undergone (from the most to the least), and have to be distinguished from starch nanoparticles, of which they are just one kind, and which can be amorphous [290].
Because starch is environmentally friendly, nano-scale starch derivatives are suggested as one of the promising biomaterials for novel utilization in foods, cosmetics, medicines as well as various composites. For example, a comparative study was developed with waxy maize starch nano-derivatives extracted through acid hydrolysis and ultrasound treatment, respectively for nanocrystals and nanoparticles. Their application in nanocomposite films was suggested to improve their morphological, structural and thermal behaviour [301]. SNC and nanoparticles were also compared in a rheological characterization of suspensions containing its nano-derivatives under different ionic strength conditions [302]. SNC were also found to serve as an effective reinforcing agent for natural rubber [303], edible films from potato starch [304], and amaranth protein films [305].
The aim of this review was to approach the most recent scientific literature dealing with natural polymers, their chemical structure, physicochemical and functional properties, in addition to their biotechnological applications. From the fundamental point of view, it was remarkable to note the preference of industry applications for natural gums when comparable with synthetic materials due to their non-toxicity, low cost, availability, biodegradability and biosafety. The use of nano-tools to process natural polymers, their derivatives or blends, is gaining prominence in the industrial field due to the advantages in the use of nanomaterials sourced from natural origin, since the use of these materials are likely to cause less environmental impact.
To the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for fellowships (LCBBC and MGCC) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) (PBSA). This study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit, the Project RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462) and COMPETE 2020 (POCI-01-0145-FEDER-006684) (JAT).
Authors have declared that no competing interests exist.
[1] |
S. Z. Goldhaber, H. Bounameaux, Pulmonary embolism and deep vein thrombosis, Lancet (London, England), 379 (2012), 1835–1846. https://doi.org/10.1016/S0140-6736(11)61904-1 doi: 10.1016/S0140-6736(11)61904-1
![]() |
[2] |
G. E. Raskob, P. Angchaisuksiri, A. N. Blanco, H. Buller, A. Gallus, B. J. Hunt, et al., Thrombosis: a major contributor to global disease burden, Arterioscler. Thromb. Vasc. Biol., 34 (2014), 2363–2371. https://doi.org/10.1161/ATVBAHA.114.304488 doi: 10.1161/ATVBAHA.114.304488
![]() |
[3] |
D. Voci, U. Fedeli, I. T. Farmakis, L. Hobohm, K. Keller, L. Valerio, et al., Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area, Thromb. Res., 212 (2022), 44–50. https://doi.org/10.1016/j.thromres.2022.02.008 doi: 10.1016/j.thromres.2022.02.008
![]() |
[4] |
I. Katsoularis, O. Fonseca-Rodríguez, P. Farrington, H. Jerndal, E. H. Lundevaller, M. Sund, et al., Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study, BMJ, 377 (2022). https://doi.org/10.1136/bmj-2021-069590 doi: 10.1136/bmj-2021-069590
![]() |
[5] |
T. N. Nguyen, M. M. Qureshi, P. Klein, H. Yamagami, M. Abdalkader, R. Mikulik, et al., Global impact of the COVID-19 pandemic on cerebral venous thrombosis and mortality, J. Stroke, 24 (2022), 256–265. https://doi.org/10.5853/jos.2022.00752 doi: 10.5853/jos.2022.00752
![]() |
[6] |
E. Berntorp, K. Fischer, D. P. Hart, M. E. Mancuso, D. Stephensen, A. D. Shapiro, et al., Haemophilia, Nat. Rev. Dis. Prim., 7 (2021), 45. https://doi.org/10.1038/s41572-021-00278-x doi: 10.1038/s41572-021-00278-x
![]() |
[7] |
K. G. Link, M. T. Stobb, M. G. Sorrells, M. Bortot, K. Ruegg, M. J. Manco‐Johnson, et al., A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A, J. Thromb. Haemost., 18 (2020), 306–317. https://doi.org/10.1111/jth.14653 doi: 10.1111/jth.14653
![]() |
[8] |
F. W. G. Leebeek, W. Miesbach, Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues, Blood, 138 (2021), 923–931. https://doi.org/10.1182/blood.2019003777 doi: 10.1182/blood.2019003777
![]() |
[9] |
S. S. G. Halfmann, N. Evangelatos, P. Schröder-Bäck, A. Brand, European healthcare systems readiness to shift from 'One-Size Fits All' to personalized medicine, Per. Med., 14 (2017), 63–74. https://doi.org/10.2217/pme-2016-0061 doi: 10.2217/pme-2016-0061
![]() |
[10] |
T. Behl, I. Kaur, A. Sehgal, S. Singh, A. Albarrati, M. Albratty, et al., The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease, Biomed. Pharmacother., 153 (2022), 113337. https://doi.org/10.1016/j.biopha.2022.113337 doi: 10.1016/j.biopha.2022.113337
![]() |
[11] |
N. M. Hamdy, E. B. Basalious, M. G. El-Sisi, M. Nasr, A. M. Kabel, E. S. Nossier, et al., Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine, Curr. Med. Res. Opin., 40 (2024), 1–19. https://doi.org/10.1080/03007995.2024.2416985 doi: 10.1080/03007995.2024.2416985
![]() |
[12] |
G. Di Minno, E. Tremoli, Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine, Haematologica, 102 (2017), 411–418. https://doi.org/10.3324/haematol.2016.156000 doi: 10.3324/haematol.2016.156000
![]() |
[13] | D. L. Ornstein, Chapter 41 - Personalized medicine for disorders of hemostasis and thrombosis, in Diagnostic Molecular Pathology (eds. W. B. Coleman and G. J. Tsongalis), Academic Press, (2024), 643–653. https://doi.org/10.1016/B978-0-12-822824-1.00006-7 |
[14] |
S. Nagalla, P. F. Bray, Personalized medicine in thrombosis: back to the future, Blood, 127 (2016), 2665–2671. https://doi.org/10.1182/blood-2015-11-634832 doi: 10.1182/blood-2015-11-634832
![]() |
[15] |
R. J. S. Preston, J. M. O'Sullivan, Personalized approaches to the treatment of hemostatic disorders, Semin. Thromb. Hemostasis, 47 (2021), 117–119. https://doi.org/10.1055/s-0041-1723800 doi: 10.1055/s-0041-1723800
![]() |
[16] |
H. Al‐Samkari, W. Eng, A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies, J. Thromb. Haemost., 20 (2022), 1077–1088. https://doi.org/10.1111/jth.15715 doi: 10.1111/jth.15715
![]() |
[17] |
X. Delavenne, E. Ollier, A. Lienhart, Y. Dargaud, A new paradigm for personalized prophylaxis for patients with severe haemophilia A, Haemophilia, 26 (2020), 228–235. https://doi.org/10.1111/hae.13935 doi: 10.1111/hae.13935
![]() |
[18] |
L. H. Bukkems, L. L. F. G. Valke, W. Barteling, B. A. P. Laros-van Gorkom, N. M. A. Blijlevens, M. H. Cnossen, et al., Combining factor Ⅷ levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A, Br. J. Clin. Pharmacol., 88 (2022), 2757–2768. https://doi.org/10.1111/bcp.15185 doi: 10.1111/bcp.15185
![]() |
[19] |
N. Mackman, W. Bergmeier, G. A. Stouffer, J. I. Weitz, Therapeutic strategies for thrombosis: new targets and approaches, Nat. Rev. Drug. Discov., 19 (2020), 333–352. https://doi.org/10.1038/s41573-020-0061-0 doi: 10.1038/s41573-020-0061-0
![]() |
[20] |
P. S. Wells, R. Ihaddadene, A. Reilly, M. A. Forgie, Diagnosis of venous thromboembolism: 20 years of progress, Ann. Intern. Med., 168 (2018), 131–140. https://doi.org/10.7326/M17-0291 doi: 10.7326/M17-0291
![]() |
[21] |
F. Khan, T. Tritschler, S. R. Kahn, M. A. Rodger, Venous thromboembolism, Lancet (London, England), 398 (2021), 64–77. https://doi.org/10.1016/S0140-6736(20)32658-1 doi: 10.1016/S0140-6736(20)32658-1
![]() |
[22] |
T. D. Martins, S. D. Martins, S. Montalvão, M. Al Bannoud, G. Y. Ottaiano, L. Q. Silva, et al., Combining artificial neural networks and hematological data to diagnose Covid-19 infection in Brazilian population, Neural Comput. Appl., 36 (2024), 4387–4399. https://doi.org/10.1007/s00521-023-09312-3 doi: 10.1007/s00521-023-09312-3
![]() |
[23] |
T. D. Martins, R. Maciel-Filho, S. A. L. Montalvão, G. S. S. Gois, M. Al Bannoud, G. Y. Ottaiano, et al., Predicting mortality of cancer patients using artificial intelligence, patient data and blood tests, Neural Comput. Appl., 36 (2024), 15599–15616. https://doi.org/10.1007/s00521-024-09915-4 doi: 10.1007/s00521-024-09915-4
![]() |
[24] |
F. W. G. Leebeek, New developments in diagnosis and management of acquired hemophilia and acquired von willebrand syndrome, HemaSphere, 5 (2021). https://doi.org/10.1097/HS9.0000000000000586 doi: 10.1097/HS9.0000000000000586
![]() |
[25] |
F. Peyvandi, G. Kenet, I. Pekrul, R. K. Pruthi, P. Ramge, M. Spannagl, Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays, J. Thromb. Haemost., 18 (2020), 1242–1255. https://doi.org/10.1111/jth.14784 doi: 10.1111/jth.14784
![]() |
[26] |
B. Pezeshkpoor, J. Oldenburg, A. Pavlova, Insights into the molecular genetic of hemophilia A and hemophilia B: The relevance of genetic testing in routine clinical practice, Hamostaseologie, 42 (2022), 390–399. https://doi.org/10.1055/a-1945-9429 doi: 10.1055/a-1945-9429
![]() |
[27] |
A. H. Kristoffersen, E. Ajzner, D. Rogic, E. Y. Sozmen, P. Carraro, A. P. Faria, et al., Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries, Thromb. Res., 142 (2016), 1–7. https://doi.org/10.1016/j.thromres.2016.04.001 doi: 10.1016/j.thromres.2016.04.001
![]() |
[28] |
M. Kafeza, J. Shalhoub, N. Salooja, L. Bingham, K. Spagou, A. H. Davies, A systematic review of clinical prediction scores for deep vein thrombosis, Phlebology, 32 (2017), 516–531. https://doi.org/10.1177/0268355516678729 doi: 10.1177/0268355516678729
![]() |
[29] |
M. T. Greene, A. C. Spyropoulos, V. Chopra, P. J. Grant, S. Kaatz, S. J. Bernstein, et al., Validation of risk assessment models of venous thromboembolism in hospitalized medical patients, Am. J. Med., 129 (2016), 1001.e9–1001.e18. https://doi.org/10.1016/j.amjmed.2016.03.031 doi: 10.1016/j.amjmed.2016.03.031
![]() |
[30] |
P. C. Silveira, I. K. Ip, S. Z. Goldhaber, G. Piazza, C. B. Benson, R. Khorasani, Performance of wells score for deep vein thrombosis in the inpatient setting, JAMA Intern. Med., 175 (2015), 1112–1117. https://doi.org/10.1001/jamainternmed.2015.1687 doi: 10.1001/jamainternmed.2015.1687
![]() |
[31] |
M. Kafeza, J. Shalhoub, N. Salooja, L. Bingham, K. Spagou, A. H. Davies, A systematic review of clinical prediction scores for deep vein thrombosis, Phlebology, 32 (2016), 516–531. https://doi.org/10.1177/0268355516678729 doi: 10.1177/0268355516678729
![]() |
[32] |
I. Nichele, A. Tosetto, Scoring Systems for Estimating the Risk of Recurrent Venous Thromboembolism, Semin. Thromb. Hemost., 43 (2017), 493–499. https://doi.org/10.1055/s-0037-1602662 doi: 10.1055/s-0037-1602662
![]() |
[33] |
A. Muñoz, C. Ay, E. Grilz, S. López, C. Font, V. Pachón, et al., A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: A development and validation study involving two independent prospective cohorts, J. Clin. Oncol., 41 (2023), 2911–2925. https://doi.org/10.1200/JCO.22.00255 doi: 10.1200/JCO.22.00255
![]() |
[34] |
F. Rodeghiero, A. Tosetto, T. Abshire, D. M. Arnold, B. Coller, P. James, et al., ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders, J. Thromb. Haemost., 8 (2010), 2063–2065. https://doi.org/10.1111/j.1538-7836.2010.03975.x doi: 10.1111/j.1538-7836.2010.03975.x
![]() |
[35] |
M. Borhany, N. Fatima, M. Abid, T. Shamsi, M. Othman, Application of the ISTH bleeding score in hemophilia, Transfus. Apher. Sci., 57 (2018), 556–560. https://doi.org/10.1016/j.transci.2018.06.003 doi: 10.1016/j.transci.2018.06.003
![]() |
[36] |
M. Khalifa, M. Albadawy, Artificial intelligence for clinical prediction: Exploring key domains and essential functions, Comput. Methods Programs Biomed. Updat., 5 (2024), 100148. https://doi.org/10.1016/j.cmpbup.2024.100148 doi: 10.1016/j.cmpbup.2024.100148
![]() |
[37] |
T. H. Tan, C. C. Hsu, C. J. Chen, S. L. Hsu, T. L. Liu, H. J. Lin, et al., Predicting outcomes in older ED patients with influenza in real time using a big data-driven and machine learning approach to the hospital information system, BMC Geriatr., 21 (2021), 280. https://doi.org/10.1186/s12877-021-02229-3 doi: 10.1186/s12877-021-02229-3
![]() |
[38] |
C. Guan, F. Ma, S. Chang, J. Zhang, Interpretable machine learning models for predicting venous thromboembolism in the intensive care unit: an analysis based on data from 207 centers, Crit. Care, 27 (2023), 406. https://doi.org/10.1186/s13054-023-04683-4 doi: 10.1186/s13054-023-04683-4
![]() |
[39] |
T. D. Martins, J. M. Annichino-Bizzacchi, A. V. C. Romano, R. Maciel Filho, Artificial neural networks for prediction of recurrent venous thromboembolism, Int. J. Med. Inform., 141 (2020), 104221. https://doi.org/10.1016/j.ijmedinf.2020.104221 doi: 10.1016/j.ijmedinf.2020.104221
![]() |
[40] |
I. Pabinger, C. Ay, Biomarkers and venous thromboembolism, Arter. Thromb. Vasc. Biol., 29 (2009), 332–336. https://doi.org/10.1161/ATVBAHA.108.182188 doi: 10.1161/ATVBAHA.108.182188
![]() |
[41] |
I. Pabinger, J. Thaler, C. Ay, Biomarkers for prediction of venous thromboembolism in cancer, Blood, 122 (2013), 2011–2018. https://doi.org/10.1182/blood-2013-04-460147 doi: 10.1182/blood-2013-04-460147
![]() |
[42] |
F. Galeano-Valle, L. Ordieres-Ortega, C. M. Oblitas, J. del-Toro-Cervera, L. Alvarez-Sala-Walther, P. Demelo-Rodríguez, Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review, Int. J. Mol. Sci., 22 (2021), 2627. https://doi.org/10.3390/ijms22052627 doi: 10.3390/ijms22052627
![]() |
[43] |
B. Jacobs, A. Obi, T. Wakefield, Diagnostic biomarkers in venous thromboembolic disease, J. Vasc. Surg. Venous Lymphat. Disord., 4 (2016), 508–517. https://doi.org/10.1016/j.jvsv.2016.02.005 doi: 10.1016/j.jvsv.2016.02.005
![]() |
[44] |
M. A. Bannoud, B. P. Gomes, M. C. de S. P. Abdalla, M. V Freire, K. Andreola, T. D. Martins, et al., Mathematical modeling of drying kinetics of ground Açaí (Euterpe oleracea) kernel using artificial neural networks, Chem. Pap., 78 (2024), 1033–1054. https://doi.org/10.1007/s11696-023-03142-2 doi: 10.1007/s11696-023-03142-2
![]() |
[45] |
M. A. Bannoud, T. D. Martins, B. F. dos Santos, Control of a closed dry grinding circuit with ball mills using predictive control based on neural networks, Digit. Chem. Eng., 5 (2022), 100064. https://doi.org/10.1016/j.dche.2022.100064 doi: 10.1016/j.dche.2022.100064
![]() |
[46] |
J. Berg, K. Nyström, Data-driven discovery of PDEs in complex datasets, J. Comput. Phys., 384 (2019), 239–252. https://doi.org/10.1016/j.jcp.2019.01.036 doi: 10.1016/j.jcp.2019.01.036
![]() |
[47] |
L. Burzawa, L. Li, X. Wang, A. Buganza-Tepole, D. M. Umulis, Acceleration of PDE-based biological simulation through the development of neural network metamodels, Curr. Pathobiol. Rep., 8 (2020), 121–131. https://doi.org/10.1007/s40139-020-00216-8 doi: 10.1007/s40139-020-00216-8
![]() |
[48] |
M. A. Bannoud, C. A. M. da Silva, T. D. Martins, Applications of metaheuristic optimization algorithms in model predictive control for chemical engineering processes: A systematic review, Annu. Rev. Control., 58 (2024), 100973. https://doi.org/10.1016/j.arcontrol.2024.100973 doi: 10.1016/j.arcontrol.2024.100973
![]() |
[49] |
M. A. Bannoud, P. H. N. Ferreira, R. R. de Andrade, C. A. M. da Silva, Control of an integrated first and second-generation continuous alcoholic fermentation process with cell recycling using model predictive control, Chem. Eng. Commun., (2024), 1–24. https://doi.org/10.1080/00986445.2024.2417901 doi: 10.1080/00986445.2024.2417901
![]() |
[50] |
Y. Zhao, C. Li, X. Liu, R. Qian, R. Song, X. Chen, Patient-specific seizure prediction via adder network and supervised contrastive learning, IEEE Trans. Neural Syst. Rehabil. Eng., 30 (2022), 1536–1547. https://doi.org/10.1109/TNSRE.2022.3180155 doi: 10.1109/TNSRE.2022.3180155
![]() |
[51] |
K. Leiderman, S. S. Sindi, D. M. Monroe, A. L. Fogelson, K. B. Neeves, The art and science of building a computational model to understand hemostasis, Semin. Thromb. Hemost., 47 (2021), 129–138. https://doi.org/10.1055/s-0041-1722861 doi: 10.1055/s-0041-1722861
![]() |
[52] |
N. Ratto, A. Bouchnita, P. Chelle, M. Marion, M. Panteleev, D. Nechipurenko, et al., Patient-specific modelling of blood coagulation, Bull. Math. Biol., 83 (2021), 50. https://doi.org/10.1007/s11538-021-00890-8 doi: 10.1007/s11538-021-00890-8
![]() |
[53] |
R. Burghaus, K. Coboeken, T. Gaub, L. Kuepfer, A. Sensse, H.-U. Siegmund, et al., Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation, PLoS One, 6 (2011), e17626. https://doi.org/10.1371/journal.pone.0017626 doi: 10.1371/journal.pone.0017626
![]() |
[54] |
C. Watson, H. Saaid, V. Vedula, J. C. Cardenas, P. K. Henke, F. Nicoud, et al., Venous thromboembolism: Review of clinical challenges, biology, assessment, treatment, and modeling, Ann. Biomed. Eng., 52 (2024), 467–486. https://doi.org/10.1007/s10439-023-03390-z doi: 10.1007/s10439-023-03390-z
![]() |
[55] |
N. N. Ramli, S. Iberahim, N. H. M. Noor, Z. Zulkafli, T. M. T. M. Shihabuddin, M. H. Din, et al., Haemostasis and inflammatory parameters as potential diagnostic biomarkers for VTE in trauma-immobilized patients, Diagnostics (Basel), 13 (2023), 150. https://doi.org/10.3390/diagnostics13010150 doi: 10.3390/diagnostics13010150
![]() |
[56] |
L. G. R. Ferreira, R. C. Figueiredo, M. das Graças Carvalho, D. R. A. Rios, Thrombin generation assay as a biomarker of cardiovascular outcomes and mortality: A narrative review, Thromb. Res., 220 (2022), 107–115. https://doi.org/10.1016/j.thromres.2022.10.007 doi: 10.1016/j.thromres.2022.10.007
![]() |
[57] |
M. S. Edvardsen, K. Hindberg, E. S. Hansen, V. M. Morelli, T. Ueland, P. Aukrust, et al., Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism, Blood Adv., 5 (2021), 224–232. https://doi.org/10.1182/bloodadvances.2020003135 doi: 10.1182/bloodadvances.2020003135
![]() |
[58] |
L. Anghel, R. Sascău, R. Radu, C. Stătescu, From classical laboratory parameters to novel biomarkers for the diagnosis of venous thrombosis, Int. J. Mol. Sci., 21 (2020), 1920. https://doi.org/10.3390/ijms21061920 doi: 10.3390/ijms21061920
![]() |
[59] |
H. Y. Lim, C. O'Malley, G. Donnan, H. Nandurkar, P. Ho, A review of global coagulation assays — Is there a role in thrombosis risk prediction?, Thromb. Res., 179 (2019), 45–55. https://doi.org/10.1016/j.thromres.2019.04.033 doi: 10.1016/j.thromres.2019.04.033
![]() |
[60] |
H. Hou, Z. Ge, P. Ying, J. Dai, D. Shi, Z. Xu, et al., Biomarkers of deep venous thrombosis, J. Thromb. Thrombolysis., 34 (2012), 335–346. https://doi.org/10.1007/s11239-012-0721-y doi: 10.1007/s11239-012-0721-y
![]() |
[61] |
D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med., 6 (2009), e1000097. https://doi.org/10.1371/journal.pmed.1000097 doi: 10.1371/journal.pmed.1000097
![]() |
[62] |
M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372 (2021), n71. https://doi.org/10.1136/bmj.n71 doi: 10.1136/bmj.n71
![]() |
[63] |
E. N. Sorensen, G. W. Burgreen, W. R. Wagner, J. F. Antaki, Computational simulation of platelet deposition and activation: I. Model development and properties, Ann. Biomed. Eng., 27 (1999), 436–448. https://doi.org/10.1114/1.200 doi: 10.1114/1.200
![]() |
[64] |
K. Boryczko, W. Dzwinel, D. A. Yuen, Modeling fibrin aggregation in blood flow with discrete-particles, Comput. Methods Programs Biomed., 75 (2004), 181–194. https://doi.org/10.1016/j.cmpb.2004.02.001 doi: 10.1016/j.cmpb.2004.02.001
![]() |
[65] |
I. V. Pivkin, P. D. Richardson, G. Karniadakis, Blood flow velocity effects and role of activation delay time on growth and form of platelet thrombi, Proc. Natl. Acad. Sci. USA, 103 (2006), 17164–17169. https://doi.org/10.1073/pnas.0608546103 doi: 10.1073/pnas.0608546103
![]() |
[66] |
Z. Xu, N. Chen, M. M. Kamocka, E. D. Rosen, M. Alber, A multiscale model of thrombus development, J. R. Soc. Interface, 5 (2008), 705–722. https://doi.org/10.1098/rsif.2007.1202 doi: 10.1098/rsif.2007.1202
![]() |
[67] |
Z. Xu, N. Chen, S. C. Shadden, J. E. Marsden, M. M. Kamocka, E. D. Rosen, et al., Study of blood flow impact on growth of thrombi using a multiscale model, Soft. Matter, 5 (2009), 769–779. https://doi.org/10.1039/B812429A doi: 10.1039/B812429A
![]() |
[68] |
Z. Xu, J. Lioi, J. Mu, M. M. Kamocka, X. Liu, D. Z. Chen, et al., A multiscale model of venous thrombus formation with surface-mediated control of blood coagulation cascade, Biophys. J., 98 (2010), 1723–1732. https://doi.org/10.1016/j.bpj.2009.12.4331 doi: 10.1016/j.bpj.2009.12.4331
![]() |
[69] |
A. M. Shibeko, E. S. Lobanova, M. A. Panteleev, F. I. Ataullakhanov, Blood flow controls coagulation onset via the positive feedback of factor Ⅶ activation by factor Xa, BMC Syst. Biol., 4 (2010), 5. https://doi.org/10.1186/1752-0509-4-5 doi: 10.1186/1752-0509-4-5
![]() |
[70] |
S. W. Jordan, E. L. Chaikof, Simulated surface-induced thrombin generation in a flow field, Biophys. J., 101 (2011), 276–286. https://doi.org/10.1016/j.bpj.2011.05.056 doi: 10.1016/j.bpj.2011.05.056
![]() |
[71] |
K. Leiderman, A. L. Fogelson, Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow, Math. Med. Biol., 28 (2011), 47–84. https://doi.org/10.1093/imammb/dqq005 doi: 10.1093/imammb/dqq005
![]() |
[72] |
A. L. Fogelson, Y. H. Hussain, K. Leiderman, Blood clot formation under flow: The importance of factor XI depends strongly on platelet count, Biophys. J., 102 (2012), 10–18. https://doi.org/10.1016/j.bpj.2011.10.048 doi: 10.1016/j.bpj.2011.10.048
![]() |
[73] |
K. Leiderman, A. L. Fogelson, The influence of hindered transport on the development of platelet thrombi under flow, Bull. Math. Biol., 75 (2013), 1255–1283. https://doi.org/10.1007/s11538-012-9784-3 doi: 10.1007/s11538-012-9784-3
![]() |
[74] |
A. Tosenberger, F. Ataullakhanov, N. Bessonov, M. Panteleev, A. Tokarev, V. Volpert, Modelling of thrombus growth in flow with a DPD-PDE method, J. Theor. Biol., 337 (2013), 30–41. https://doi.org/10.1016/j.jtbi.2013.07.023 doi: 10.1016/j.jtbi.2013.07.023
![]() |
[75] |
A. Sequeira, T. Bodnár, Blood coagulation simulations using a viscoelastic model, Math. Model. Nat. Phenom., 9 (2014), 34–45. https://doi.org/10.1051/mmnp/20149604 doi: 10.1051/mmnp/20149604
![]() |
[76] |
A. Tosenberger, N. Bessonov, V. Volpert, Influence of fibrinogen deficiency on clot formation in flow by hybrid model, Math. Model. Nat. Phenom., 10 (2015), 36–47. https://doi.org/10.1051/mmnp/201510102 doi: 10.1051/mmnp/201510102
![]() |
[77] |
O. S. Rukhlenko, O. A. Dudchenko, K. E. Zlobina, G. T. Guria, Mathematical modeling of intravascular blood coagulation under wall shear stress, PLoS One, 10 (2015), e0134028. https://doi.org/10.1371/journal.pone.0134028 doi: 10.1371/journal.pone.0134028
![]() |
[78] |
J. Pavlova, A. Fasano, J. Janela, A. Sequeira, Numerical validation of a synthetic cell-based model of blood coagulation, J. Theor. Biol., 380 (2015), 367–379. https://doi.org/10.1016/j.jtbi.2015.06.004 doi: 10.1016/j.jtbi.2015.06.004
![]() |
[79] |
A. Piebalgs, X. Y. Xu, Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow, J. R. Soc. Interface, 12 (2015), 20150949. https://doi.org/10.1098/rsif.2015.0949 doi: 10.1098/rsif.2015.0949
![]() |
[80] |
Z. Li, A. Yazdani, A. Tartakovsky, G. E. Karniadakis, Transport dissipative particle dynamics model for mesoscopic advection-diffusion-reaction problems, J. Chem. Phys., 143 (2015), 14101. https://doi.org/10.1063/1.4923254 doi: 10.1063/1.4923254
![]() |
[81] |
A. Bouchnita, K. Bouzaachane, T. Galochkina, P. Kurbatova, P. Nony, V. Volpert, An individualized blood coagulation model to predict INR therapeutic range during warfarin treatment, Math. Model. Nat. Phenom., 11 (2016), 28–44. https://doi.org/10.1051/mmnp/201611603 doi: 10.1051/mmnp/201611603
![]() |
[82] |
J. H. Seo, T. Abd, R. T. George, R. Mittal, A coupled chemo-fluidic computational model for thrombogenesis in infarcted left ventricles, Am. J. Physiol. Heart Circ. Physiol., 310 (2016), H1567–82. https://doi.org/10.1152/ajpheart.00855.2015 doi: 10.1152/ajpheart.00855.2015
![]() |
[83] |
M. N. Ngoepe, Y. Ventikos, Computational modelling of clot development in patient-specific cerebral aneurysm cases, J. Thromb. Haemost., 14 (2016), 262–272. https://doi.org/10.1111/jth.13220 doi: 10.1111/jth.13220
![]() |
[84] |
A. Bouchnita, T. Galochkina, V. Volpert, Influence of antithrombin on the regimes of blood coagulation: Insights from the mathematical model, Acta Biotheor., 64 (2016), 327–342. https://doi.org/10.1007/s10441-016-9291-2 doi: 10.1007/s10441-016-9291-2
![]() |
[85] |
E. V. Dydek, E. L. Chaikof, Simulated thrombin generation in the presence of surface-bound heparin and circulating tissue factor, Ann. Biomed. Eng., 44 (2016), 1072–1084. https://doi.org/10.1007/s10439-015-1377-5 doi: 10.1007/s10439-015-1377-5
![]() |
[86] |
J. Pavlova, A. Fasano, A. Sequeira, Numerical simulations of a reduced model for blood coagulation, Zeitschrift für Angew. Math. und Phys., 67 (2016), 28. https://doi.org/10.1007/s00033-015-0610-2 doi: 10.1007/s00033-015-0610-2
![]() |
[87] |
A. Tosenberger, F. Ataullakhanov, N. Bessonov, M. Panteleev, A. Tokarev, V. Volpert, Modelling of platelet-fibrin clot formation in flow with a DPD-PDE method, J. Math. Biol., 72 (2016), 649–681. https://doi.org/10.1007/s00285-015-0891-2 doi: 10.1007/s00285-015-0891-2
![]() |
[88] |
V. Govindarajan, V. Rakesh, J. Reifman, A. Y. Mitrophanov, Computational study of thrombus formation and clotting factor effects under venous flow conditions, Biophys. J., 110 (2016), 1869–1885. https://doi.org/10.1016/j.bpj.2016.03.010 doi: 10.1016/j.bpj.2016.03.010
![]() |
[89] |
C. Ou, W. Huang, M. M.-F. Yuen, A computational model based on fibrin accumulation for the prediction of stasis thrombosis following flow-diverting treatment in cerebral aneurysms, Med. Biol. Eng. Comput., 55 (2017), 89–99. https://doi.org/10.1007/s11517-016-1501-1 doi: 10.1007/s11517-016-1501-1
![]() |
[90] |
A. Yazdani, H. Li, J. D. Humphrey, G. E. Karniadakis, A general shear-dependent model for thrombus formation, PLoS Comput. Biol., 13 (2017), e1005291. https://doi.org/10.1371/journal.pcbi.1005291 doi: 10.1371/journal.pcbi.1005291
![]() |
[91] |
H. Hosseinzadegan, D. K. Tafti, Prediction of thrombus growth: Effect of stenosis and reynolds number, Cardiovasc. Eng. Technol., 8 (2017), 164–181. https://doi.org/10.1007/s13239-017-0304-3 doi: 10.1007/s13239-017-0304-3
![]() |
[92] |
L. M. Haynes, T. Orfeo, K. G. Mann, S. J. Everse, K. E. Brummel-Ziedins, Probing the dynamics of clot-bound thrombin at venous shear rates, Biophys. J., 112 (2017), 1634–1644. https://doi.org/10.1016/j.bpj.2017.03.002 doi: 10.1016/j.bpj.2017.03.002
![]() |
[93] |
H. Kamada, Y. Imai, M. Nakamura, T. Ishikawa, T. Yamaguchi, Shear-induced platelet aggregation and distribution of thrombogenesis at stenotic vessels, Microcirculation, 24 (2017). https://doi.org/10.1111/micc.12355 doi: 10.1111/micc.12355
![]() |
[94] |
J. D. Horn, D. J. Maitland, J. Hartman, J. M. Ortega, A computational thrombus formation model: application to an idealized two-dimensional aneurysm treated with bare metal coils, Biomech. Model. Mechanobiol., 17 (2018), 1821–1838. https://doi.org/10.1007/s10237-018-1059-y doi: 10.1007/s10237-018-1059-y
![]() |
[95] |
R. Méndez Rojano, S. Mendez, F. Nicoud, Introducing the pro-coagulant contact system in the numerical assessment of device-related thrombosis, Biomech. Model. Mechanobiol., 17 (2018), 815–826. https://doi.org/10.1007/s10237-017-0994-3 doi: 10.1007/s10237-017-0994-3
![]() |
[96] |
B. Gu, A. Piebalgs, Y. Huang, C. Longstaff, A. D. Hughes, R. Chen, et al., Mathematical modelling of intravenous thrombolysis in acute ischaemic stroke: Effects of dose regimens on levels of fibrinolytic proteins and clot lysis time, Pharmaceutics, 11 (2019), 111. https://doi.org/10.3390/pharmaceutics11030111 doi: 10.3390/pharmaceutics11030111
![]() |
[97] |
K. Ayabe, S. Goto, H. Oka, H. Yabushita, M. Nakayama, A. Tomita, et al., Potential different impact of inhibition of thrombin function and thrombin generation rate for the growth of thrombi formed at site of endothelial injury under blood flow condition, Thromb. Res., 179 (2019), 121–127. https://doi.org/10.1016/j.thromres.2019.05.007 doi: 10.1016/j.thromres.2019.05.007
![]() |
[98] |
J. Chen, S. L. Diamond, Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa, PLoS Comput. Biol., 15 (2019), e1007266. https://doi.org/10.1371/journal.pcbi.1007266 doi: 10.1371/journal.pcbi.1007266
![]() |
[99] |
A. Bouchnita, V. Volpert, A multiscale model of platelet-fibrin thrombus growth in the flow, Comput. Fluids, 184 (2019), 10–20. https://doi.org/10.1016/j.compfluid.2019.03.021 doi: 10.1016/j.compfluid.2019.03.021
![]() |
[100] |
H. Hosseinzadegan, D. K. Tafti, A predictive model of thrombus growth in stenosed vessels with dynamic geometries, J. Med. Biol. Eng., 39 (2019), 605–621. https://doi.org/10.1007/s40846-018-0443-5 doi: 10.1007/s40846-018-0443-5
![]() |
[101] |
O. E. Kadri, V. D. Chandran, M. Surblyte, R. S. Voronov, In vivo measurement of blood clot mechanics from computational fluid dynamics based on intravital microscopy images, Comput. Biol. Med., 106 (2019), 1–11. https://doi.org/10.1016/j.compbiomed.2019.01.001 doi: 10.1016/j.compbiomed.2019.01.001
![]() |
[102] |
J. Du, D. Kim, G. Alhawael, D. N. Ku, A. L. Fogelson, Clot permeability, agonist transport, and platelet binding kinetics in arterial thrombosis, Biophys. J., 119 (2020), 2102–2115. https://doi.org/10.1016/j.bpj.2020.08.041 doi: 10.1016/j.bpj.2020.08.041
![]() |
[103] |
W. T. Wu, M. Zhussupbekov, N. Aubry, J. F. Antaki, M. Massoudi, Simulation of thrombosis in a stenotic microchannel: The effects of vWF-enhanced shear activation of platelets, Int. J. Eng. Sci., 147 (2020), 103206. https://doi.org/10.1016/j.ijengsci.2019.103206 doi: 10.1016/j.ijengsci.2019.103206
![]() |
[104] |
A. Bouchnita, K. Terekhov, P. Nony, Y. Vassilevski, V. Volpert, A mathematical model to quantify the effects of platelet count, shear rate, and injury size on the initiation of blood coagulation under venous flow conditions, PLoS One, 15 (2020), e0235392. https://doi.org/10.1371/journal.pone.0235392 doi: 10.1371/journal.pone.0235392
![]() |
[105] |
Z. L. Liu, D. N. Ku, C. K. Aidun, Mechanobiology of shear-induced platelet aggregation leading to occlusive arterial thrombosis: A multiscale in silico analysis, J. Biomech., 120 (2021), 110349. https://doi.org/10.1016/j.jbiomech.2021.110349 doi: 10.1016/j.jbiomech.2021.110349
![]() |
[106] |
V. N. Kaneva, J. L. Dunster, V. Volpert, F. Ataullahanov, M. A. Panteleev, D. Y. Nechipurenko, Modeling thrombus shell: Linking adhesion receptor properties and macroscopic dynamics, Biophys. J., 120 (2021), 334–351. https://doi.org/10.1016/j.bpj.2020.10.049 doi: 10.1016/j.bpj.2020.10.049
![]() |
[107] |
A. Yazdani, Y. Deng, H. Li, E. Javadi, Z. Li, S. Jamali, et al., Integrating blood cell mechanics, platelet adhesive dynamics and coagulation cascade for modelling thrombus formation in normal and diabetic blood, J. R. Soc. Interface., 18 (2021), 20200834. https://doi.org/10.1098/rsif.2020.0834 doi: 10.1098/rsif.2020.0834
![]() |
[108] |
C. Ma, Y. Ren, Q. Zheng, J. Wang, A computational model on cartesian adaptive grid for thrombosis simulation, IEEE Access, 10 (2022), 67694–67702. https://doi.org/10.1109/ACCESS.2022.3184123 doi: 10.1109/ACCESS.2022.3184123
![]() |
[109] |
R. Méndez Rojano, A. Lai, M. Zhussupbekov, G. W. Burgreen, K. Cook, J. F. Antaki, A fibrin enhanced thrombosis model for medical devices operating at low shear regimes or large surface areas, PLoS Comput. Biol., 18 (2022), e1010277. https://doi.org/10.1371/journal.pcbi.1010277 doi: 10.1371/journal.pcbi.1010277
![]() |
[110] |
M. Rezaeimoghaddam, F. N. van de Vosse, Continuum modeling of thrombus formation and growth under different shear rates, J. Biomech., 132 (2022), 110915. https://doi.org/10.1016/j.jbiomech.2021.110915 doi: 10.1016/j.jbiomech.2021.110915
![]() |
[111] | A. S. Pisaryuk, N. M. Povalyaev, A. V Poletaev, A. M. Shibeko, Systems biology approach for personalized hemostasis correction, J. Pers. Med., 12 (2022). https://doi.org/10.3390/jpm12111903 |
[112] |
M. Zhussupbekov, R. Méndez Rojano, W. T. Wu, J. F. Antaki, von Willebrand factor unfolding mediates platelet deposition in a model of high-shear thrombosis, Biophys. J., 121 (2022), 4033–4047. https://doi.org/10.1016/j.bpj.2022.09.040 doi: 10.1016/j.bpj.2022.09.040
![]() |
[113] |
Y. Wang, J. Luan, K. Luo, T. Zhu, J. Fan, Multi-constituent simulation of thrombosis in aortic dissection, Int. J. Eng. Sci., 184 (2023), 103817. http://dx.doi.org/10.1016/j.ijengsci.2023.103817 doi: 10.1016/j.ijengsci.2023.103817
![]() |
[114] |
R. Petkantchin, A. Rousseau, O. Eker, K. Zouaoui Boudjeltia, F. Raynaud, B. Chopard, A simplified mesoscale 3D model for characterizing fibrinolysis under flow conditions, Sci. Rep., 13 (2023), 13681. https://doi.org/10.1038/s41598-023-40973-1 doi: 10.1038/s41598-023-40973-1
![]() |
[115] |
K. Miyazawa, A. L. Fogelson, K. Leiderman, Inhibition of platelet-surface-bound proteins during coagulation under flow Ⅱ: Antithrombin and heparin, Biophys. J., 122 (2023), 230–240. https://doi.org/10.1016/j.bpj.2022.10.038 doi: 10.1016/j.bpj.2022.10.038
![]() |
[116] |
A. R. Rezaie, S. T. Olson, Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex: Demonstration by rapid kinetics studies, Biochemistry, 39 (2000), 12083–12090. https://doi.org/10.1021/bi0011126 doi: 10.1021/bi0011126
![]() |
[117] |
M. Anand, K. Rajagopal, K. R. Rajagopal, A model for the formation, growth, and lysis of clots in quiescent plasma: A comparison between the effects of antithrombin Ⅲ deficiency and protein C deficiency, J. Theor. Biol., 253 (2008), 725–738. https://doi.org/10.1016/j.jtbi.2008.04.015 doi: 10.1016/j.jtbi.2008.04.015
![]() |
[118] | M. J. Griffith, The heparin-enhanced antithrombin Ⅲ/thrombin reaction is saturable with respect to both thrombin and antithrombin Ⅲ, J. Biol. Chem., 257 (1982), 13302–13899. |
[119] | M. J. Griffith, Kinetics of the heparin-enhanced antithrombin Ⅲ/thrombin reaction. Evidence for a template model for the mechanism of action of heparin, J. Biol. Chem., 257 (1982), 7360–7365. |
[120] |
C. M. Danforth, T. Orfeo, K. G. Mann, K. E. Brummel-Ziedins, S. J. Everse, The impact of uncertainty in a blood coagulation model, Math. Med. Biol., 26 (2009), 323–336. https://doi.org/10.1093/imammb/dqp011 doi: 10.1093/imammb/dqp011
![]() |
[121] |
P. P. Naidu, M. Anand, Importance of Ⅷa inactivation in a mathematical model for the formation, growth, and lysis of clots, Math. Model. Nat. Phenom., 9 (2014), 17–33. https://doi.org/10.1051/mmnp/20149603 doi: 10.1051/mmnp/20149603
![]() |
[122] |
F. Saitta, J. Masuri, M. Signorelli, S. Bertini, A. Bisio, D. Fessas, Thermodynamic insights on the effects of low-molecular-weight heparins on antithrombin Ⅲ, Thermochim. Acta, 713 (2022), 179248. https://doi.org/10.1016/j.tca.2022.179248 doi: 10.1016/j.tca.2022.179248
![]() |
[123] |
H. Minakami, M. Morikawa, T. Yamada, T. Yamada, Candidates for the determination of antithrombin activity in pregnant women, J. Perinat. Med., 39 (2011), 369–374. https://doi.org/10.1515/jpm.2011.026 doi: 10.1515/jpm.2011.026
![]() |
[124] | K. C. Jones, K. G. Mann, A model for the tissue factor pathway to thrombin. Ⅱ: A mathematical simulation, J. Biol. Chem., 269 (1994), 23367–23373. |
[125] |
M. F. Hockin, K. C. Jones, S. J. Everse, K. G. Mann, A model for the stoichiometric regulation of blood coagulation, J. Biol. Chem., 277 (2002), 18322–18333. https://doi.org/10.1074/jbc.m201173200 doi: 10.1074/jbc.m201173200
![]() |
[126] |
R. Méndez Rojano, S. Mendez, D. Lucor, A. Ranc, M. Giansily-Blaizot, J. F. Schved, et al., Kinetics of the coagulation cascade including the contact activation system: sensitivity analysis and model reduction, Biomech. Model. Mechanobiol., 18 (2019), 1139–1153. https://doi.org/10.1007/s10237-019-01134-4 doi: 10.1007/s10237-019-01134-4
![]() |
[127] |
M. S. Chatterjee, W. S. Denney, H. Jing, S. L. Diamond, Systems biology of coagulation initiation: Kinetics of thrombin generation in resting and activated human blood, PLOS Comput. Biol., 6 (2010), e1000950. https://doi.org/10.1371/journal.pcbi.1000950 doi: 10.1371/journal.pcbi.1000950
![]() |
[128] |
A. Ranc, S. Bru, S. Mendez, M. Giansily-Blaizot, F. Nicoud, R. Méndez Rojano, Critical evaluation of kinetic schemes for coagulation, PLoS One, 18 (2023), e0290531. https://doi.org/10.1371/journal.pone.0290531 doi: 10.1371/journal.pone.0290531
![]() |
[129] |
M. F. Hockin, K. C. Jones, S. J. Everse, K. G. Mann, A model for the stoichiometric regulation of blood coagulation, J. Biol. Chem., 277 (2002), 18322–18333. https://doi.org/10.1074/jbc.m201173200 doi: 10.1074/jbc.m201173200
![]() |
[130] |
D. Luan, M. Zai, J. D. Varner, Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies, PLoS Comput. Biol., 3 (2007), 1347–1359. https://doi.org/10.1371/journal.pcbi.0030142 doi: 10.1371/journal.pcbi.0030142
![]() |
[131] |
K. G. Link, M. T. Stobb, J. Di Paola, K. B. Neeves, A. L. Fogelson, S. S. Sindi, et al., A local and global sensitivity analysis of a mathematical model of coagulation and platelet deposition under flow, PLoS One, 13 (2018), e0200917. https://doi.org/10.1371/journal.pone.0200917 doi: 10.1371/journal.pone.0200917
![]() |
![]() |
![]() |
1. | Diogo Ribeiro, Alexsander Carvalho Júnior, Gustavo Vale de Macedo, Vitor Chagas, Lucas Silva, Brenda Cutrim, Deivid Santos, Bruno Soares, Adrielle Zagmignan, Rita de Miranda, Priscilla de Albuquerque, Luís Nascimento da Silva, Polysaccharide-Based Formulations for Healing of Skin-Related Wound Infections: Lessons from Animal Models and Clinical Trials, 2019, 10, 2218-273X, 63, 10.3390/biom10010063 | |
2. | Sharmaine Atencio, Alicia Maestro, Esther Santamaría, José María Gutiérrez, Carmen González, Encapsulation of ginger oil in alginate-based shell materials, 2020, 37, 22124292, 100714, 10.1016/j.fbio.2020.100714 | |
3. | Monika Szymańska-Chargot, Monika Chylińska, Karolina Gdula, Arkadiusz Kozioł, Artur Zdunek, Isolation and Characterization of Cellulose from Different Fruit and Vegetable Pomaces, 2017, 9, 2073-4360, 495, 10.3390/polym9100495 | |
4. | Sunil Kumar, Jalal Foroozesh, Chitin nanocrystals based complex fluids: A green nanotechnology, 2021, 257, 01448617, 117619, 10.1016/j.carbpol.2021.117619 | |
5. | Marthyna P. Souza, Antônio F. M. Vaz, Thacianna B. Costa, Miguel A. Cerqueira, Célia M. M. B. De Castro, António A. Vicente, Maria G. Carneiro-da-Cunha, Construction of a Biocompatible and Antioxidant Multilayer Coating by Layer-by-Layer Assembly of κ-Carrageenan and Quercetin Nanoparticles, 2018, 11, 1935-5130, 1050, 10.1007/s11947-018-2077-6 | |
6. | Gerardo Leyva-Gómez, Elizabeth Piñón-Segundo, Néstor Mendoza-Muñoz, María Zambrano-Zaragoza, Susana Mendoza-Elvira, David Quintanar-Guerrero, Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art, 2018, 19, 1422-0067, 1549, 10.3390/ijms19061549 | |
7. | Viney Sharma, Rajiv Kumar, Narinder Arora, Simranjit Singh, Navjeet Sharma, Amit Anand, Subheet Kumar Jain, Shuchi Sharma, Effect of heat treatment on thermal and mechanical stability of NaOH-doped xanthan gum-based hydrogels, 2020, 24, 1432-8488, 1337, 10.1007/s10008-020-04641-y | |
8. | Daniel Roger Bezerra Amorim, Felipe Silva Bellucci, Aldo Eloizo Job, Iran da Silva Guimarães, Helder Nunes da Cunha, Electrical, structural and thermal properties of new conductive blends (PANICG) based on polyaniline and cashew gum for organic electronic, 2019, 136, 1388-6150, 1615, 10.1007/s10973-018-7778-6 | |
9. | Sara Amirnejat, Aliakbar Nosrati, Shahrazad Javanshir, M. Reza Naimi-Jamal, Superparamagnetic alginate-based nanocomposite modified by L-arginine: An eco-friendly bifunctional catalysts and an efficient antibacterial agent, 2020, 152, 01418130, 834, 10.1016/j.ijbiomac.2020.02.212 | |
10. | Priscilla Barbosa Sales Albuquerque, Weslley Felix de Oliveira, Priscila Marcelino dos Santos Silva, Maria Tereza dos Santos Correia, John F. Kennedy, Luana Cassandra Breitenbach Barroso Coelho, Epiphanies of well-known and newly discovered macromolecular carbohydrates – A review, 2020, 156, 01418130, 51, 10.1016/j.ijbiomac.2020.04.046 | |
11. | Jenyffer Medeiros Campos, Ibrahim M. Banat, Leonie Asfora Sarubbo, 2019, 9781315271767, 242, 10.1201/b21950-10 | |
12. | Sara Amirnejat, Aliakbar Nosrati, Shahrzad Javanshir, Superparamagnetic Fe 3 O 4 @Alginate supported L‐arginine as a powerful hybrid inorganic–organic nanocatalyst for the one‐pot synthesis of pyrazole derivatives , 2020, 34, 0268-2605, 10.1002/aoc.5888 | |
13. | Evrim Elcin, Huseyin Avni Öktem, Immobilization of fluorescent bacterial bioreporter for arsenic detection, 2020, 18, 2052-336X, 137, 10.1007/s40201-020-00447-2 | |
14. | Kashif Akram, Hafiz Muhammad Shahbaz, Gui-Ran Kim, Umar Farooq, Joong-Ho Kwon, Improved Extraction and Quality Characterization of Water-Soluble Polysaccharide from Gamma-IrradiatedLentinus edodes, 2017, 82, 00221147, 296, 10.1111/1750-3841.13590 | |
15. | Nahideh Asadi, Azizeh Rahmani Del Bakhshayesh, Soodabeh Davaran, Abolfazl Akbarzadeh, Common biocompatible polymeric materials for tissue engineering and regenerative medicine, 2020, 242, 02540584, 122528, 10.1016/j.matchemphys.2019.122528 | |
16. | Jingkun Zhao, Ce Sun, Haiyan Li, Xu Dong, Xiaodong Zhang, Studies on the physicochemical properties, gelling behavior and drug release performance of agar/κ-carrageenan mixed hydrogels, 2020, 154, 01418130, 878, 10.1016/j.ijbiomac.2020.03.087 | |
17. | Michał Kuczak, Ewa Kurczyńska, Cell Wall Composition as a Marker of the Reprogramming of the Cell Fate on the Example of a Daucus carota (L.) Hypocotyl in Which Somatic Embryogenesis Was Induced, 2020, 21, 1422-0067, 8126, 10.3390/ijms21218126 | |
18. | Ana Grenha, Ana D. Alves, Filipa Guerreiro, Jacinta Pinho, Sandra Simões, António José Almeida, Maria Manuela Gaspar, Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection, 2020, 147, 09396411, 38, 10.1016/j.ejpb.2019.11.009 | |
19. | Manaf AlMatar, Essam A. Makky, Aizi Nor Mazila Ramli, Natural Polysaccharides Alleviate Neurological Disorders: New Updates, 2022, 22, 13895575, 2813, 10.2174/1389557522666220321145840 | |
20. | A. S. López-Díaz, L. L. Méndez-Lagunas, Mucilage-Based Films for Food Applications, 2022, 8755-9129, 1, 10.1080/87559129.2022.2123501 | |
21. | Agnieszka Folentarska, Jakub Łagiewka, Magdalena Krystyjan, Wojciech Ciesielski, Biodegradable Binary and Ternary Complexes from Renewable Raw Materials, 2021, 13, 2073-4360, 2925, 10.3390/polym13172925 | |
22. | Azin Paydayesh, Seyed Rasoul Mousavi, Sara Estaji, Hossein Ali Khonakdar, Mohammad Amin Nozarinya, Functionalized graphene nanoplatelets/poly (lactic acid)/chitosan nanocomposites: Mechanical, biodegradability, and electrical conductivity properties, 2022, 43, 0272-8397, 411, 10.1002/pc.26385 | |
23. | Qurratul Ain Zakirah Mohd Zamram, Hannis Fadzillah Mohsin, Mashani Mohamad, Nurul Aqmar Mohamad Nor Hazalin, Khuriah Abdul Hamid, Physical Characterisation and Stability Study of Formulated Chromolaena odorata Gel, 2022, 19, 15672018, 479, 10.2174/1567201818666210419114809 | |
24. | Sandip Murtale, Prakash Goudanavar, Ankit Acharya, Jaytheertha Lokapur, R. S. Chitti, Jeet Bahadur Moktan, Application of natural and modified Polymers in Novel Drug Delivery: A review, 2021, 0974-360X, 6732, 10.52711/0974-360X.2021.01163 | |
25. | Duarte Nuno Carvalho, Rui L. Reis, Tiago H. Silva, Marine origin materials on biomaterials and advanced therapies to cartilage tissue engineering and regenerative medicine, 2021, 9, 2047-4830, 6718, 10.1039/D1BM00809A | |
26. | Priscilla Barbosa Sales Albuquerque, Weslley Felix de Oliveira, Priscila Marcelino dos Santos Silva, Maria Tereza dos Santos Correia, John F. Kennedy, Luana Cassandra Breitenbach Barroso Coelho, Skincare application of medicinal plant polysaccharides — A review, 2022, 277, 01448617, 118824, 10.1016/j.carbpol.2021.118824 | |
27. | Bushra Naureen, Bee Chin Ang, Farina Muhamad, A. S. M. A. Haseeb, W. J. Basirun, Κappa-Carrageenan Modified Polyurethane Foam Scaffolds for Skeletal Muscle Tissue Engineering, 2023, 1566-2543, 10.1007/s10924-022-02747-0 | |
28. | Ravinder Kumar, Naresh Kumar, Vishnu D. Rajput, Saglara Mandzhieva, Tatiana Minkina, Baljeet Singh Saharan, Dharmender Kumar, Pardeep Kumar Sadh, Joginder Singh Duhan, Advances in Biopolymeric Nanopesticides: A New Eco-Friendly/Eco-Protective Perspective in Precision Agriculture, 2022, 12, 2079-4991, 3964, 10.3390/nano12223964 | |
29. | Manita Thakur, Manisha Chandel, Anita Rani, Ajay Sharma, 2022, 1411, 9780841297807, 1, 10.1021/bk-2022-1411.ch001 | |
30. | Manaf AlMatar, Essam A. Makky, Aizi Nor Mazila Ramli, Nesibe Ebru Kafkas, Fatih Köksal, Polysaccharides to Combat Viruses (COVID-19) and Microbes: New updates, 2022, 15, 18744672, 803, 10.2174/1874467215666220112150332 | |
31. | Bruna Alves Martins, Priscilla Barbosa Sales de Albuquerque, Marthyna Pessoa de Souza, Bio-based Films and Coatings: Sustainable Polysaccharide Packaging Alternatives for the Food Industry, 2022, 30, 1566-2543, 4023, 10.1007/s10924-022-02442-0 | |
32. | Ibukunoluwa Fola Olawuyi, Soo Rin Kim, Won Young Lee, Application of plant mucilage polysaccharides and their techno-functional properties’ modification for fresh produce preservation, 2021, 272, 01448617, 118371, 10.1016/j.carbpol.2021.118371 | |
33. | Mariano Michelon, Guilherme de Figueiredo Furtado, Raphaela Araujo Mantovani, Rosiane Lopes Cunha, 2022, Chapter 2, 978-3-030-83569-9, 3, 10.1007/978-3-030-83570-5_2 | |
34. | Melike Kantarcıoğlu, Merve Gökşin Karaaslan Tunç, Canbolat Gürses, Burhan Ateş, Süleyman Köytepe, Fabrication, thermal and in vitro behaviors of ciprofloxacin loaded β-cyclodextrin-PEG based polyurethanes as potential biomaterial for wound dressing applications, 2022, 59, 1060-1325, 329, 10.1080/10601325.2022.2048954 | |
35. | Danijela Stanisić, Marija Tasić, Olivera Stamenković, Ljubica Tasić, 2022, Chapter 13, 978-981-16-6161-7, 415, 10.1007/978-981-16-6162-4_13 | |
36. | Eze F. Ahuekwe, Patrick O. Isibor, Paul A. Akinduti, Abimbola O. Salami, Chinedu C. Onuselogu, Oyewumi O. Oshamika, Olusola L. Oyesola, Tersagh Ichor, Olawale M. Ezekiel, Olubukola Oziegbe, Abimbola D. Akinyosoye, Fadekemi Akinhanmi, John O. Oyewale, Olugbenga S. Taiwo, Ruth A. Akinwunmi, Ibukun Ajiboye, Bosede T. Adekeye, Sharon O. Akinpelu, Alice D. Kuye, Adetutu O. Bello, Dango Z. George, Olusola A. Ojo-Omoniyi, Taiwo S. Popoola, Oluwatobi D. Akinyemi, Glory P. Adebayo, Margaret I. Oniha, Franklyn N. Iheagwam, Comfort A. Adelodun, Kesioluwa E. Orukotan, Olayemi F. Bilewu, Elizabeth A. Onibokun, Nifemi O. Fasuyi, Obinna C. Nwinyi, Isaac O. Ayanda, Conrad A. Omonhinmin, Olayemi O. Akinnola, Solomon U. Oranusi, Angela O. Eni, Jacob O. Popoola, Grace I. Olasehinde, Olawole O. Obembe, 2023, 9780323855938, 483, 10.1016/B978-0-323-85593-8.00013-8 | |
37. | Rashid Sulthan, Arunima Reghunadhan, Sreedha Sambhudevan, A new era of chitin synthesis and dissolution using deep eutectic solvents- comparison with ionic liquids, 2023, 380, 01677322, 121794, 10.1016/j.molliq.2023.121794 | |
38. | Deepanjan Datta, Viola Colaco, Sony Priyanka Bandi, Himanshu Sharma, Namdev Dhas, Prabhanjan S. Giram, 2025, 9780443137747, 263, 10.1016/B978-0-443-13774-7.00007-4 | |
39. | Xueqin Gao, Madhu Sharma, Aarti Bains, Prince Chawla, Gulden Goksen, Jian Zou, Wanli Zhang, Application of seed mucilage as functional biopolymer in meat product processing and preservation, 2024, 339, 01448617, 122228, 10.1016/j.carbpol.2024.122228 | |
40. | A. N. Zarubina, A. N. Ivankin, Biodegradable Polymer Materials Based on Polyvinyl Alcohol, Starch, and Cellulose Derivatives, 2024, 17, 1995-4212, 461, 10.1134/S1995421224700795 | |
41. | Jonatas Fernando Cavalini de Moraes, Daniele Zendrini Rechenchoski, André Luiz Dyna, Arcelina Pacheco Cunha, Nágila Maria Pontes Silva Ricardo, Silvana Silveira de Farias, Selene Maia de Morais, Lucy Megumi Yamauchi, Ligia Carla Faccin-Galhardi, Characterization and Promising in vitro Antiherpetic Effect of Galactomannan from Delonix regia Seeds, 2024, 81, 0343-8651, 10.1007/s00284-024-03903-6 | |
42. | ERİNÇ KOÇAK, OZLEM K. ESMER, ASLI SAHINER, Optimization of the conditions of alkaline extraction of tomato peels and characterization of tomato peel extracts obtained under atmospheric and oxygen free conditions, 2023, 95, 1678-2690, 10.1590/0001-3765202320220077 | |
43. | Esther Santamaría, Alicia Maestro, Carmen González, Encapsulation of Carvacrol-Loaded Nanoemulsion Obtained Using Phase Inversion Composition Method in Alginate Beads and Polysaccharide-Coated Alginate Beads, 2023, 12, 2304-8158, 1874, 10.3390/foods12091874 | |
44. | Simranjeet Singh, Lav Singh, Vijay Kumar, Wahid Ali, Praveen C. Ramamurthy, Daljeet Singh Dhanjal, Nikhita Sivaram, Ruby Angurana, Joginder Singh, Vimal Chandra Pandey, Nadeem A. Khan, Algae-based approaches for Holistic wastewater management: A low-cost paradigm, 2023, 345, 00456535, 140470, 10.1016/j.chemosphere.2023.140470 | |
45. | Gianluca Viscusi, Elisa Boccalon, Elena Lamberti, Morena Nocchetti, Giuliana Gorrasi, Alginate Microbeads Containing Halloysite and Layered Double Hydroxide as Efficient Carriers of Natural Antimicrobials, 2024, 14, 2079-4991, 232, 10.3390/nano14020232 | |
46. | Nikita Kaushik, Md Salik Noorani, Kritika Shukla, Mohd. Aamir Mirza, Sunny Dhir, Amenah S. Alotaibi, Zahid Hameed Siddiqui, CTAB Protocol for Obtaining High-Quality Total RNA from Hibiscus rosa-sinensis and Other Related Plants of the Family Malvaceae, 2024, 9, 2470-1343, 20359, 10.1021/acsomega.4c00877 | |
47. | Sara Hedayati, Mohammad Tarahi, Elham Ashrafi-Dehkordi, 2024, 9780443138423, 131, 10.1016/B978-0-443-13842-3.00005-8 | |
48. | Lukman Nulhakim, Reviana Inda Dwi Suyatmo, Flora Elvistia Firdaus, Rendhy Prasetia Utama, Siti Jariah, Eko Prabowo, Reyhan Syahreza Muslim, 2023, Chapter 21, 978-94-6463-147-0, 196, 10.2991/978-94-6463-148-7_21 | |
49. | Fatma Bilge EMRE, Nilüfer KIVILCIM, Kontrollü Metotreksat Salımı İçin Selüloz Temelli Poliüretan Yapıların Sentezi ve Yapısal Özelliklerinin Karakterizasyonu, 2023, 11, 2148-2446, 2176, 10.29130/dubited.1208589 | |
50. | Great Iruoghene Edo, Emad Yousif, Mohammed H. Al-Mashhadani, Modified chitosan: Insight on biomedical and industrial applications, 2024, 275, 01418130, 133526, 10.1016/j.ijbiomac.2024.133526 | |
51. | Duarte Nuno Carvalho, Cristiana Gonçalves, Rita O. Sousa, Rui L. Reis, J. Miguel Oliveira, Tiago H. Silva, Extraction and Purification of Biopolymers from Marine Origin Sources Envisaging Their Use for Biotechnological Applications, 2024, 26, 1436-2228, 1079, 10.1007/s10126-024-10361-5 | |
52. | Valeria S. Garcia, Luis M. Gugliotta, Carolina G. Gutierrez, Verónica D. G. Gonzalez, κ-Carrageenan Hydrogels as a Sustainable Alternative for Controlled Release of New Biodegradable Molecules with Antimicrobial Activities, 2024, 32, 1566-2543, 3795, 10.1007/s10924-024-03189-6 | |
53. | Isolation and nanoformulation of mucilage from Abelmoschus esculentus (okra) biomass and evaluation of its biological activities and biocompatibility, 2024, 2190-6815, 10.1007/s13399-024-05655-6 | |
54. | Maha A. Alharbi, Amani A. Alrehaili, Mona Othman I. Albureikan, Amal F. Gharib, Hussam Daghistani, Maha M. Bakhuraysah, Ghfren S. Aloraini, Mohammed A. Bazuhair, Hayaa M. Alhuthali, Ahmed Ghareeb, In vitrostudies on the pharmacological potential, anti-tumor, antimicrobial, and acetylcholinesterase inhibitory activity of marine-derivedBacillus velezensisAG6 exopolysaccharide, 2023, 13, 2046-2069, 26406, 10.1039/D3RA04009G | |
55. | Makyson R.S. Leal, Luiza R.A. Lima, Natalie E.R. Rodrigues, Paulo A.G. Soares, Maria G. Carneiro-da-Cunha, Priscilla B.S. Albuquerque, A review on the biological activities and the nutraceutical potential of chitooligosaccharides, 2024, 00086215, 109336, 10.1016/j.carres.2024.109336 |
Source | Name | Type | Reference |
Tree gum exudates | Arabic gum | Arabinogalactan | [21] |
Prosopis alba gum | Arabinogalactan | [22] | |
Acacia tortuosa gum | Arabinogalactan | [23] | |
Almond gum | Arabinogalactan | [24] | |
Albizia stipulata gum | Arabinogalactan | [25] | |
Acacia senegal gum | Arabinogalactan | [26] | |
Cashew gum | Galactan with glucose,arabinose,rhamnose,mannose and glucuronic acid units | [27] | |
Extracts | Pectin | Galacturonic acid with rhamnose,arabinose,galactose,xylose,and glucose units | [28] |
Seeds | Cassia spectabilis gum | Galactomannan | [29] |
Guar gum | Galactomannan | [30] | |
Cassia nodosa gum | Galactomannan | [31] | |
Cassia grandis gum | Galactomannan | [32] | |
Fenugreek | Galactomannan | [33] | |
Locust bean gum | Galactomannan | [34] | |
Starch | Glucan | [35] | |
Hymenaea courbaril gum | Xyloglucan | [36] | |
Red seaweeds | Agar | Galactan | [37] |
Carrageenans | Galactan | [38] | |
Brown seaweeds | Alginate | Mannuronic acid with guluronic acid units | [39] |
Microbial | Xanthan gum | Glucan | [40] |
Cellulose | Glucan | [6] | |
Animal | Chitin | Glucosamine | [41] |
Hyaluronic acid | Glucosamine with glucuronic acid units | [42] | |
Chondroitin sulphate | Galactosamine with glucuronic acid units | [43] |
Source | Name | Type | Reference |
Tree gum exudates | Arabic gum | Arabinogalactan | [21] |
Prosopis alba gum | Arabinogalactan | [22] | |
Acacia tortuosa gum | Arabinogalactan | [23] | |
Almond gum | Arabinogalactan | [24] | |
Albizia stipulata gum | Arabinogalactan | [25] | |
Acacia senegal gum | Arabinogalactan | [26] | |
Cashew gum | Galactan with glucose,arabinose,rhamnose,mannose and glucuronic acid units | [27] | |
Extracts | Pectin | Galacturonic acid with rhamnose,arabinose,galactose,xylose,and glucose units | [28] |
Seeds | Cassia spectabilis gum | Galactomannan | [29] |
Guar gum | Galactomannan | [30] | |
Cassia nodosa gum | Galactomannan | [31] | |
Cassia grandis gum | Galactomannan | [32] | |
Fenugreek | Galactomannan | [33] | |
Locust bean gum | Galactomannan | [34] | |
Starch | Glucan | [35] | |
Hymenaea courbaril gum | Xyloglucan | [36] | |
Red seaweeds | Agar | Galactan | [37] |
Carrageenans | Galactan | [38] | |
Brown seaweeds | Alginate | Mannuronic acid with guluronic acid units | [39] |
Microbial | Xanthan gum | Glucan | [40] |
Cellulose | Glucan | [6] | |
Animal | Chitin | Glucosamine | [41] |
Hyaluronic acid | Glucosamine with glucuronic acid units | [42] | |
Chondroitin sulphate | Galactosamine with glucuronic acid units | [43] |